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ABSTRACT 
 
 
 
Citrus Bioactive Compounds Influencing Phase II Detoxifying Enzymes: Potential For 
Cancer Chemoprevention. (May 2007) 
Jose Luis Perez, B.S., University of Texas Pan-American 
Chair of Advisory Committee: Dr. Bhimanagouda S. Patil 
 
Several cell culture and animal studies demonstrated that citrus limonoids have 
protective effects against certain types of cancer. These chemopreventive properties of 
citrus limonoids are attributed to the induction of phase II enzyme, glutathione S-
transferase (GST). In the current study, six citrus limonoids and two modified limonoids 
were utilized for the evaluation of NAD(P)H: quinone reductase (QR)  activity and 
glutathione S-tranferase (GST) activity against 1-chloro-2,4-dinitrobenzene (CDNB) and 
4-nitroquinoline 1-oxide (4NQO) in A/J female mice.  
In liver, limonoids that induced phase II enzyme activity were limonin-7-
methoxime (32% CBNB), (270% 4NQO), (65% QR); and deacetylnomilin (180% QR). 
In stomach, limonin-7-methoxime (51% 4NQO); deacetyl nomilinic acid glucoside 
(55% 4NQO), nomilin (58% CDNB), (75% 4NQO); isoobacunoic acid (25% CDNB); 
deacetylnomilin (19% CDNB); limonoid mixture (45% 4NQO), (200% QR). 
Furthermore, in intestine, nomilin (280% 4NQO); deacetylnomilin (73% 4NQO), (22% 
QR); and the limonoid mixture (93% 4NQO) increase enzymatic activity. Finally in lung, 
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deacetyl nomilinic acid glucoside (67% CDNB); limonin-7-methoxime (32% QR); and 
defuran limonin (45% QR) diplayed induction properties. 
Furthermore, D-glucaric acid (GA), a chemoprotective compound found in fruits 
and vegetables, was quantified using High Performance Liquid Chromatography 
(HPLC) grapefruit. Nine widely used grapefruit varieties were analyzed for the levels of 
D-glucaric acid. Seasonal levels of GA in each of the grapefruit varieties tested were 
found to be Thompson (58.36-126.8 mg/100ml), Henderson (29.6-49.7 mg/100ml), Rio 
Red (40.0-58.8mg/100ml), Star Ruby (25.5-46.7 mg/100ml), I-48 (26.6-58.3 mg/100ml), 
Ruby Red (49.3-63.0 mg/100ml), Ray’s Ruby (58.2-72.1 mg/100ml), Marsh (53.7-65.8 
mg/100ml) and Duncan (50.17 mg/100ml). The HPLC method developed for the 
quantification of D-glucaric acid was found to be simple, fast, and reproducible. 
Additionally, the labor intensity and cost of sample preparation were greatly reduced.  
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CHAPTER I 
INTRODUCTION 
History revealed that human illnesses were treated using traditional medicine, 
presently known as complementary or alternative medicines (Issa, Volate, & Wargovich, 
2006). Written and archeological records dating back over 5000 years suggest the use of 
plant and plant products as treatments for ill physiological conditions (Raskin et al., 
2002).  Furthermore, in 480 BC, Hippocrates stated that “Positive health requires a 
knowledge of man’s primary constitution and the powers of various foods, both those 
natural to him and those resulting from human skill”, in other words genetics and diet 
influence health (Reddy, Odhav, & Bhoola, 2003). In recent nutritional research, the 
focus has shifted from the traditional study of vitamin and mineral deficiencies to the 
study of naturally occurring bioactive compounds having important effects on human 
health (Ejaz, Ejaz, Matsuda, & Lim, 2006).  Knowledge of traditional medicine has 
paved the way for contemporary medicine. This is significant mainly in research 
involving cancer. From 1981-2002, a total of 1031 new chemical compounds were 
discovered for the treatment of various diseases, of which 57-67% were of natural origin.  
Among the medications used to treat or prevent cancers, approximately 75% of them are 
of natural origin (Newmann, Cragg, & Snader, 2003).  In developed countries, the 
practice of contemporary medicine is mainly observed; however, 80% of the population 
of developing countries still rely on the use of traditional medicine (Kim et al., 2005).   
_______________              
This thesis follows the style of Food Chemistry. 
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 The role of the consumption of fruits and vegetables in maintaining human 
health has been investigated by many researchers in the last two decades. Several recent 
reviews have evaluated benefits of consumption of fruits and vegetables and prevention 
of the onset of cardiovascular diseases and cancer (Steinmetz & Potter, 1996; van’t Veer, 
Jansen, Klerk, & Kok, 2000; Surh, 2003; Mandel, Paker, Youdim, & Weinbreb, 2005). 
Studies show that limited consumption of fruits and vegetables  increases the risk of 
lung, esophagus, bladder, prostate  and stomach cancer by about two times compared to 
individuals with more frequent intake (Ejaz, Ejaz, Matsuda, & Lim, 2006).   
During the last decade, health maintaining properties of citrus have been 
extensively studied using cell culture and animal models. Citrus fruits have been 
reported to induce hypocholesteroleic responses, enhance antioxidants in serum, prevent 
osteoporosis, and contain certain compounds that act as anticancer agent (Kurowska, et 
al., 2000b; Deyhim et al., 2006; Jayaprakasha, & Patil,  2007; Yu, Wang, Walzem, 
Miller, Pike, & Patil, 2005; Vanamala, Reddivari, Yoo, Pike, & Patil, 2006; Tanaka et 
al., 1997; Tanaka et al., 1998; Kim et al., 2005; Miyagi, Om, Chee, & Bennink, 2000). 
 Among different citrus species, grapefruit contains a range of bioactive 
compounds that have the potential to protect against carcinogenesis (Miyata, Takano, 
Takahashi, Sasaki, & Yamazoe, 2002).   Among the compounds that have shown 
biological activity are flavonoids, pectin, vitamin C, folic acid, coumarin-related 
compounds, fibers, and limonoids (Patil, Brodbelt, Miller, & Turner, 2006).   
 The biological activities of citrus limonoids have been evaluated on several cell 
culture and animal model systems. Citrus limonoids have been shown to inhibit HIV-1 
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replication on infected human mononuclear cells (Battinelli et al. 2003). In two Japanese 
studies, it was reported that orange juice and citrus limonoids, obacunone and limonin, 
played an important role in the inhibition of azoxymethane-induced colon cancer 
(Miyagi, Om, Chee, & Bennink 2000; Tanaka et al., 2000). Furthermore, evidence 
shows that bioactive compounds found in grapefruit (one of them is limonin) protect 
against azoxymethane (AOM) induced abberant crypt foci (Vanamala, Reddivari, Yoo, 
Pike, & Patil, 2006).  Inhibition of 7,12-dimethylbenz[a]anthracene-induced oral tumors 
by citrus limonoids has been the focus of in other laboratories (Miller, Porter, Binnie, 
Guo, & Hasegawa, 2004; Miller, Fanous, Rivera-Hidago, Hasegawa, & Lam, 1989). 
Strong evidence suggests that benzo[a]pyrene induced forestomach neoplasia in mice 
was inhibited by citrus limonoids (Lam & Hasegawa, 1989).  Recently several cell 
culture studies have been conducted to observe the effects of citrus limonoids on various 
cell lines.   
 The chemopreventive properties of citrus limonoids have in some cases been 
attributed to their ability to induce phase II enzyme activity, mainly GST. Several 
studies have evaluated the ability of certain limonoids to induce GST activity in animal 
models (Lam, Li, & Hasegawa, 1989; Lam & Hasegawa 1989; Tanaka et al., 2000; 
Ahmad, Li, Polson, Mackie, Quiroga, & Patil, 2006; Kelly, Jewell, & O’Brien, 2003). 
The induction of GST activity has been correlated to the chemical structural components 
of citrus limonoids. 
In addition to citrus limonoids, it has been observed that citrus also contains D-
glucaric acid (Walaszek, Szemraj, Hanausek, Sherman, & Adams, 1996; Dwivedi, Heck, 
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Downie, Larroya, & Webb, 1990).  Glucaric acid (GA), a compound whose presence has 
been reported in various fruits and vegetable, has also shown to be a potential anticancer 
agent. Accumulating evidence has positively correlated the consumption of dietary 
glucaric acid and cancer prevention (Walaszek, Hanausek-Walaszek, Minton, & Webb, 
1986; Abou-Issa, Duruibe, Minton, Larroya, Dwivedi, & Webb, 1988; Abou-Issa, 1995; 
Walaszek, Flores, & Adams, 1988; Walaszek, 1990; Dwivedi, Downie, & Webb, 1989; 
Yoshimi, Walaszek, Mori, Hanasuek, Szeraj, & Slaga, 2000; Oredipe, Barth, Hanausek-
Walaszek, Sautins, & Walaszek, 1987; Oredipe, Barth , Dwivedi, & Webb, 1992; Boone, 
1992). 
 Many studies have demonstrated the effect of GA on different breast cancers at 
different stages of carcinogenesis. GA has been shown to inhibit 7,12 
dimethylben[a]anthracene-induced mammary tumorogenesis (Walaszek, Hanausek-
Walaszek, Minton, & Webb, 1986; Abou-Issa, Duruibe, Minton, Larroya, Dwivedi, & 
Webb, 1988). Furthermore, the effect of GA on the initiation and promotion stages of 
carcinogenesis was evaluated. Results from this study show that replication of breast 
tumors was reduced by 28% in the initiation stage and 42% at the promotion stage 
(Abou-Issa, 1995). In another study, it was shown that GA reduced estrogen receptors 
found on mammary carcinomas. The reduction of these receptors was correlated with a 
reduction of tumor growth (Walaszek, Flores, & Adams, 1988).  
 Anti-cancer properties of GA have also been investigated on other organs. In 
lung cancer induced by benzo(a)pyrene, GA proved to be an effective inhibitor in mice 
(Walaszek, 1990). In colon, GA was shown to inhibit the incidence and reduced the size 
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of colon and intestinal cancers (Dwivedi, Oredipe, Barth, Downie, & Webb, 1989), and 
azoxymethane–induced rat colon carcinogenesis (Yoshimi, Walaszek, Mori, Hanasuek, 
Szeraj, & Slaga, 2000). GA has demonstrated an inhibitory effect on the initiation and 
promotion of hapatocarcinogenesis (Oredipe, Barth, Hanausek-Walaszek, Sautins, & 
Walaszek, 1987; Oredipe, Barth, Dwivedi, & Webb, 1992). In skin cancer, GA and its 
precursor (1,4)-glucarolactone were shown to inhibit certain preliminary skin cancer 
biomarkers (Boone, 1992). 
It is possible that chemopreventive properties of citrus may be attributed to the 
synergistic effects of two groups of anticancer agents, GA and limonoids. The possible 
mode of anticancer action may be through induction of phase II enzymes such as, 
glutathione S-transferase (GST), NAD(P)H: quinone reductase (QR), and UDP-
glucuronosyltransferase (UDPGT). The objective of this investigation is to evaluate the 
potential of various structurally different citrus limonoids to induce phase II enzymes 
GST and QR in A/J female mice. Additionally, an analytical method for the 
quantification of D-glucaric acid in grapefruit varieties was also developed.  
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CHAPTER II 
LITERATURE REVIEW 
Chemoprevention potential of fruits and vegetables has been a topic that has 
captured the attention of researchers and consumers alike. The concept of 
chemoprevention is based on the potential biological activities of pharmaceuticals or 
dietary constituents which can inhibit or reverse the process of carcinogenesis (Walaszek, 
Hanausek, & Slaga, 2004).  Carcinogenesis is a multi-step process consisting of three 
critical stages: initiation, promotion, and progression. The first step, initiation of 
carcinogenesis is a process, in which xenobiotics and some endogenous agents cause the 
damage of cellular DNA. The damaged DNA leads to the activation of oncogenes and 
inactivation of tumor suppressor genes, promotion. The promotion phase is a process 
that occurs over a long period of time and is usually reversible if detected early. The 
final stage of carcinogenesis is the progression phase. In this phase, damage experience 
on DNA in the earlier phases cause benign tumor to convert to malignant tumors which 
are capable of affecting surrounding tissues and metastasizing to distant sites (Walaszek, 
Hanausek, & Slaga, 2004).  In order for bioactive compounds to be chemopreventive, 
one or more of the stages of carcinogenesis has to be blocked and or suppressed.  Factors 
involved in these processes include, phase I enzymes, oxidative enzyme pathways, 
induction of phase II detoxifying enzymes, scavenging of reactive metabolites, altering 
DNA repair mechanism, inhibition of cell proliferation and inhibition of inflammation, 
and  modulation of cell differentiation and apoptosis (Hanausek, Walaszek, & Slaga, 
2003).  
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2.1. Citrus limonoids 
 Two decades ago, limonoids received more attention by the citrus industry due to 
their impact on bitterness in juice.  During early investigations, limonin, was considered 
the more bitter compound, which caused a major concern in the juice industry and led to 
development of debittering techniques.  In later studies, other limonoids, nomilin and 
obacunone, were also found to be responsible for the bitterness of citrus products.  
Currently, 37 limonoid aglycones and 17 limonoid glucosides have been identified (Roy, 
& Saraf, 2006). Limonoids are a group of highly oxygenated, terpenoids found in great 
proportion in Meliaceae and Rutaceae plants (Roy, & Saraf, 2006). Limonoids are 
present as secondary metabolites in plants which are reported to have significant 
antifeedant activity (Ruberto, Renda, Tringali, Napoli, & Simmonds, 2002). The typical 
limonoid structure contains mainly a 4,4,8-trimethyl-17-furanylsteroid skeleton (Fig 1). 
Furthermore, citrus limoniods are found in aglycone (bitter) and glucoside (tasteless) 
forms (Hasegawa, 2000)  
 
 
                                       
Fig.1. Structure of nomilin as an example of the typical limonoid structure 
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 The biosynthesis of citrus limonoids is achieved in the phloem region via the 
terpenoid biosynthestic pathway (Ou, Hasegawa, Herman, & Fong, 1988). It is 
postulated that nomilin is the precursor of all of the limonoids isolated from Citrus. 
Nomilin, upon biosynthesis, is translocated to other parts of the plants, leaves, fruit, 
peels, and seed. Further, nomilin is converted to other limonoid aglycones by several 
pathways: limonin, calamine, ichangensin, and 7-acetate limonoid pathways (Hasegawa, 
Herman, Orme, & Ou, 1986). Each of these pathways yields a variety of different 
limonoids. In this study, we utilized limonoids produced by the limonin pathways. 
During maturation, these limonoid aglycones are converted to 17--D-glucopyranoside 
derivatives, mainly in fruit tissues and seeds (Hasegawa, 2000).  The conversion of 
aglycones to glucosides is carried out by UDP-D-glucose:limonoid glucosyl transferase 
(Hasegawa, Suhayda, Hsu, & Robertson, 1997). Evidence suggests that the level of this 
enzyme is higher in sweet oranges as opposed to pummelo and its hybrids which are 
bitter even in late season (Ohta, & Hasegawa, 1995; Hsu, Berhow, Robertson, & 
Hasegawa, 1998). Commercially sold citrus juices contain low levels of limonoid 
aglycones, but high levels of limonoid glucosides.  For example, glucoside levels in 
orange juice, grapefruit juice, and lemon juice are 320, 195 and 90 ppm, respectively 
(Lam, Li, & Hasegawa, 1989).  
2.2. Citrus limonoids and potential cancer prevention 
 Accumulating results from decades of research provide conclusive evidence 
about the chemopreventive properties of citrus limonoids. Nomilin has been observed to 
reduce the number of mice with benzo[a]pyrene (BP)-induced tumors from 100-72%, 
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additionally the number of tumors per mouse was also decreased.  Furthermore, limonin 
was less active as a chemopreventive agent compared to other limonoids. In another 
model of cancer protection, limonin and nomilin were also tested in the protection 
against 7,12-dimethylbenzy[a]anthracene (DMBA)-induced buccal carcinogenesis 
(Miller, Fanous, Rivera-Hidalgo, Hasegawa, & Lam, 1989). Interestingly, limonin, in 
the DMBA induced carcinogenesis model, was reported to reduce tumor burden by 60%, 
while nomilin was less inhibitory.  
 Early experiments involving cancer prevention in animal models have proposed 
that nomilin, in general, is a more potent inhibitor than limonin. Limonin on the other 
hand, was observed to be a potent inhibitor in the promotion phase of carcinogenesis 
(Lam, Hasegawa, Bergstrom, Lam, & Kenney, 2000). Nomilin was found to reduce the 
number of benzo[a]pyrene induced fore stomach tumors by 50%, to inhibit 
carcinogenesis induced by DMBA in a two stage model, and to inhibit 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis by 36%. 
Furthermore, limonin in the two stage model was observed to inhibit the promotion of 
carcinogenesis by TPA.  
 As citrus limonoid research progressed, new limonoids were reported (Miller, 
Porter, Binnie, Guo, & Hasegawa, 2004). In this study, new limonoids, ichangensin, 
obacunone, and deoxylimonin, were examined to determine their effect on the inhibition 
of DMBA induced oral tumors. The activity of these limonoids was compared to the 
previously reported nomilin and limonin. Data from this study showed that, obacunone 
reduced tumor number (25%) and burden (40%). In addition, deoxylimonin, lacking the 
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epoxide group on the D-ring, also reduced tumor number and burden by 30% and 50 %, 
respectively. Data from initial studies showed that an intact A ring on the limonoid 
structure is essential for chemoprevention (Miller, Taylor, Berry, Zimmermann, & 
Hasegawa, 2000). Furthermore, it was observed that modifications to the D-ring did not 
affect biological activity (Miller, Taylor, Berry, Zimmermann, & Hasegawa, 2000, 
Miller, Porter, Binnie, Guo, & Hasegawa, 2004).  
 In addition to animal studies, citrus limonoids have also been tested on human 
cancer cell lines. Several citrus limonoids were inhibitory to the proliferation of estrogen 
receptor negative (MDA-MB-435) and receptor-positive (MCF-7) breast cancer cells 
(Guthrie, Morley, Hasegawa, Manners, & Vandenberg, 2000). Citrus limonoid 
glucosides were proven to be lethal at micromolar concentrations for neuroblastoma 
cells in culture, while normal cells were not affected (Poulose, Harris, & Patil, 2005). 
Furthermore, limonoid agylcones were shown to significantly shorten viability of cancer 
cell lines SH-SY5Y neuroblastoma and Caco-2 colonic adenocarcinoma, while non-
cancerous Chinese hamster ovary cells did not showed any change in cell numbers or 
morphology (Poulose, Harris, & Patil, 2006).  In a previous study, several human cancer 
cell lines were used to evaluate the effects of citrus limonoids. In this study, specific 
limonoids showed cytotoxicity on MCF-7 breast cancer cells (Tian, Miller, Ahmad, 
Tang, & Patil, 2001).  
2.3. Glutathione S-transferase 
Chemoprevention by citrus limonoids has been repeatedly attributed to the 
induction of GST activity. A study in the Netherlands evaluated the effect on habitual 
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consumption of fruits and vegetables on rectal GST. It seems that consumption of citrus 
fruit was positively correlated with human rectal GST activity (Wark et al., 2004).  
Several studies have attributed the induction of these enzymes to the structural 
components of limonoids (Kelly, Jewell, & O’Brien, 2003; Lam, Li, & Hasegawa, 1989; 
Lam, Sparnins, Wattenburg, 1982). In 1989 alone, three reports were published on 
chemoprevention by citrus limonoids. Lam and Hasegawa (1989) reported the use of 
citrus limonoids, nomilin and limonin, as chemopreventive agents in ICR/Ha mice. 
Nomilin was observed to induce GST activity 2.48 to 3.44 times in liver and 3.00 to 4.17 
in intestine compared to the control. The limonin treatment group showed only slight 
induction of GST capabilities. Due to the fact that some induction of GST activity was 
observed by citrus limonoids, eight limonoids of varying structural variation were 
analyzed in mice. The most induction of GST activity was observed in the cytosol of the 
small intestine mucosa of the nomilin treated mice followed by obacunone, isoobacunoic 
acid, and ichangin (Lam, Li, & Hasegawa, 1989). Other limonoids tested in this study 
(limonin, limonol, and deoxylimonin), were mild or inactive GST inducers. Further 
studies demonstrate that dietary obacunone elevates GST and QR in liver significantly 
against azoxymethane (AOM)-induced aberrant crypt foci at 4 weeks, while limonin 
increase only QR Activity (Tanaka et al., 2000). GST induction activity was later tested 
using a nomilin, limonin and aglycone mixture (Ahmad, Li, Polson, Mackie, Quiroga, & 
Patil, 2006). In the stomach, all three limonoids increased GST activity, while in the 
liver only nomilin induced GST activity. Results from this study provided supporting 
evidence for Lam, Li, & Hasegawa’s (1989) previous findings, that protection against 
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chemical carcinogenesis is prominent in the stomach. Recent animal studies reported 
that limonoids affect induction of GST activity in a dose-dependent manner (Kelly, 
Jewell, & O’Brien, 2003). Data showed that GST activity increased in a dose dependent 
fashion in the liver in limonin and nomilin fed animals, while only nomilin increased 
GST activity in the small intestine.  
The furan moiety has been thought to be one of the components responsible for 
induction of GST activity (Lam, Li, & Hasegawa, 1989). Two furan containing 
diterpenes, kahweol and cafestol, isolated from green coffee beans were shown to induce 
GST activity in various tissues in mice (Lam, Sparnins, Wattenburg, 1982). In a later 
study, eight citrus limonoids were tested for induction of GST activity in mice.  In this 
study, the authors looked at the structure-function relationship of different citrus 
limonoids and their effect on GST activity (Lam, Li, & Hasegawa, 1989). 
  GSTs are thought to play a curial physiological role in the initial stages of 
detoxification of potential alkylating agents (Booth, Boyland, & Sims, 1961). GST 
enzymes catalyze the adduct formation of glutathione (GSH), a tripeptide consisting of 
glycine, glutamic acid, and cysteine, with electrophilic xenobiotics (Beutler, Duron, & 
Kelly, 1963). GST catalyzes the reaction of xenobiotic and other environmental factors 
to react with the –SH of glutathione, neutralizing the toxin and making it more water 
soluble (Habig, Pabst, & Jacoby, 1974). GST enables the conjugation of GSH to 
electrophilic toxins. An increase in the activity of GST usually enhances the ability of an 
organism to detoxify carcinogens. Therefore, any substance that increases the activity of 
GST may be a potential anti-carcinogen with the ability to inhibit chemically induced 
  
13 
 
cancer formation (Lam, Li, & Hasegawa, 1989; Hahn-Obercyger, Stark, & Madar, 2005). 
In 2005, a study was completed on the effect of grapefruit and oroblanco on hepatic 
detoxification in rats. The data from this study indicated that citrus consumption has a 
positive impact on phase II enzymes glutathione S-transferase and NAD(P)H: quinone 
reductase (Hahn-Obercyger, Stark, & Madar, 2005).  
2.4. NAD(P)H: quinone reductase 
  NAD(P)H: quinone reductase (QR) is important in the protection against toxic 
and neoplastic effects of xenobiotics.  QR catalyses the two electron reduction of 
quinones to protect cells from free radicals and reactive oxygen species that arise from 
one electron reduction. Quinones are toxic products of oxidative metabolism of aromatic 
hydrocarbons (Horning, Thenot, & Helton, 1978). The reduction of quinones can lead to 
their detoxification or to the production of biologically reactive products depending 
upon the mechanism of reaction and subsequent deposition of hydroquinone products 
(Benson, Hunkeler, & Talalay, 1980). In a previous study, nimbolide, a limonoid 
isolated from neem flowers, showed induction of QR activity in Hepa1c1c7 cells 
(Sritanaudomchai et al., 2005). Furthermore, Tanaka et al. (2000) have reported the 
induction of QR by certain citrus limonoids. 
2.5. UDP-glucuronosyltransferase 
In the case of, UDP-glucuronosyltransferase, a different approach is taken. UDP-
glucuronosyltransferase (UDPGT) catalyzes a biosynthetic reaction called 
glucuronidation. Glucuronidation, a major drug metabolizing reaction, increases the 
polarity of xenobiotic agents by conjugating the electrophile with glucuronic acid. The 
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product of this conjugation reaction is then excreted in bile or urine as glucuronides, thus 
potential carcinogenic agents from the body are removed (Miner & Mackenzie, 1991; 
Shipkova & Wieland, 2005). Glucuronidation leads to significant reduction in the toxic 
or pharmacological activity of electrophilic substances (Walaszek, 1990). Glucuronides 
are then excreted in urine or bile. As bile travels through the intestinal track, it can 
become a substrate for -glucuronidase. Interestingly, -glucuronidase counteracts the 
action of UDPGT by de-conjugating the xenobiotic back to its electrophilic state, 
allowing its re-absorption and enterohepatic circulation (Walaszek, 1990). In de-
glucuronidation, the action of the UDPGT is reversed. -glucuronidase deconjugates the 
compound bound to glucuronic acid making it available to interact or be transported to 
other areas in the biological system (Dwivedi, Downie, & Webb, 1987). Furthermore, -
glucuronidase is known to be highly inhibited by (1,4)-glucarolactone. At physiological 
pH, glucaric acid is in equilibrium with (1,4)-glucarolactone and (6,3)-glucacrolactone 
(Horton & Walaszek, 1982), but when glucaric acid is orally administered it is converted 
to (1,4)-glucarolactone (Walaszek, Hanausek-Walaszek, Minton, & Webb, 1986). (1,4)-
Glucarolactone does not directly interact or modify the activity of UDPGA, but inhibits 
the deconjugation of xenobiotics, therefore increasing the net glucuronidation. In vivo, 
metabolism of glucaric acid to (1,4) glucolactone  has been shown to increase  the 
detoxification of carcinogens and inhibit chemical carcinogenesis by inhibiting -
glucuronidase (Lampe, Li, Potter, & King, 2002).  
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2.6. D-glucaric acid 
 Glucaric acid, or D-glucarate in its salt form, is a non-toxic natural compound 
produced in small amount in mammals and by a few plants (Walaszek, Szemaraj, 
Hanausek, Adams, & Sherman, 1996). Glucaric acid is an end metabolite of the D-
glucuronic acid pathway metabolism in mammals (Marsh, 1963). The product of the 
oxidation of D-glucuronic acid yields glucaric acid (GA), D-glucaro-1,4-lactone (1,4-
GL) and D-glucaro-6,3-lactone (6,3-GL). These compounds have been observed to be 
excreted normally in human urine (Walaszek, Szemraj, Hanausek, Adams, & Sherman, 
1996). The excretion was used as an indirect indicator of hepatic microsomal enzymes 
induction by exogenous chemicals or xenobiotics (Dutton, 1980). GA has also been 
measured in fruits and vegetables (Dwivedi, Heck, Downie, Larroya, & Webb, 1990; 
Walaszek, Szemaraj, Hanausek, Adams, & Sherman, 1996). Several studies have 
evaluated the health aspect of GA on various biological systems. Many of these studies 
observed that the consumption of dietary GA was an effective chemoprevention strategy. 
Researchers attributed this activity to the effect of 1,4-GL on glucuronidation (Dwivedi, 
Heck, Downie, Larroya, & Webb, 1990). Glucuronidation is a process in which phase II 
enzyme UDPGT conjugates xenobiotics making them more polar by addition of a 
glucuronide moiety in order to facilitate their expulsion from the body, therefore 
removing toxins from the body (Shimoi & Nakayama, 2005; Shipkova & Wieland, 
2005). The conjugated products are then excreted in bile or urine. In some instances, the 
conjugated products are deconjugated by -glucuronidase (Dwivedi, Downie, & Webb, 
1987). In the deconjugation process, or deglucuronidation, -glucuronidase hydrolyses 
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the glucuronide moiety, therefore reintroducing the toxin into circulation throughout the 
body (Speaker, Backman, & Kroemer, 1997). Several studies have shown that 1,4-GL is 
a potent inhibitor of  -glucuronidase (Levvy, 1952; Marsh, 1963; Kushinsky & Chen, 
1967; Marselos, Dutton, & Hanninen, 1975; Narita, Nagai, Hagiwara, Aburada, Yokoi, 
& Kamataki, 1993).  Since both GA and its precursor, 1,4-GL, are present  in fruits and 
vegetables, dietary modulation of  -glucuronidase was investigated (Lampe, Li, Potter, 
& King, 2002).  It seems that an inverse association of serum -glucuronidase activity 
and plant-food intake in humans exists. 
2.7. D-glucaric acid chemistry and biological activities 
 In 1949, the inhibitory properties of D-glucarate on animal -glucuronidase were 
investigated. In this study, it was found that GA strongly inhibited the activity of -
glucuronidase (Karunairatnam & Levvy 1949). In the following year, several studies 
were published on the extent of inhibition of GA on -glucuronidase (Karunairatnam, 
Kerr, & Levvy, 1949; Karunairatnam & Levvy 1951, Mills, Paul & Smith 1953; 
Campbell, 1949). In 1952, a report by G.A. Levvy stated that the compound actually 
responsible for the inhibition of -glucuronidase was saccharo-1,4-lactone (1,4-GL). 1,4-
GL was found to be a very powerful inhibitor of -glucuronidase having an affinity 240 
times greater than that of phenolphthalein glucuronide, a substrate with the highest know 
affinity for -glucuronidase at the time.  
Following these findings researchers began investigating how these interactions 
between enzymes and compounds could be used. In 1957, Boyland, Gasson, & Williams 
deduced that orally administering 1,4-GL to men exposed to carcinogenic aromatic 
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amine would reduce the amount of free carcinogens which were released by the action 
of -glucuronidase against conjugation. A later study in Japan, reported that 1,4-GL, was 
absorbed through the intestinal tract and distributed throughout the body when 
administered orally (Kiyomoto, Harigaya, Ohshima, & Morita, 1963). The 
bioavailability of 1,4-GL was also reported, 10-20 % of the orally administered lactone 
was excreted in urine and more than half of the lactones remained unchanged after a few 
hours post administration. Studies carried out by Charles Marsh in the early to mid 
1960’s highlighted the importance of the inhibition of  -glucuronidase by 1,4-GL 
(Marsh, 1963; Marsh & Reid, 1963; Marsh & Carr, 1965). The results of Marsh’s work 
demonstrated that GA and its precursors were normal constituents of urine. These 
constituents were present in small amounts in the liver and other tissues. The inhibition 
of -glucuronidase also sparked the curiosity of other researchers on how different 
parameters might influence the activity of 1,4-GL on enzymatic activity. In 1967, a 
study was carried out analyzing the inhibition of -glucuronidase in bovine liver. It was 
found that the interconversion between GA and the inhibitory 1,4-GL was dependent on 
pH, temperature and time.  Furthermore, the pH optima of -glucuronidase changed in 
the presence of 1,4-GL (Kushinsky & Chen, 1967). 
 Reports of the structure of GA and its precursors were initially produced in the 
late 1970’s– early 1980’s.  In 1976, a report was published on the crystalline structure of 
1,4-GL monohydrate (Gress & Jeffrey, 1976). The main focus of this study was to 
elucidate the structural information of 1,4-GL in a crystalline state as compared to in 
solution. In a later study, the conformation of both GA and its lactone were studied by 
  
18 
 
the use of nuclear magnetic resonance (NMR) spectrometry (Horton & Walaszek, 1982). 
It was demonstrated that GA and its lactones (1,4-GL and 6,3-GL) are in equilibrium in 
solution.  
Now that the presence of GA in urine was proven and information on the 
chemical behavior of GA and its precursor was available, Charles Marsh reported the 
biosynthesis of GA in mammals. His earlier work showed that GA is excreted at a rate 
of 30-100 mol per day (Marsh, 1985). In 1986, Marsh reported that in the presence of 
iron salts and hydrogen peroxide, D-Glucuronic acid was converted into GA. The 
reaction inhibited by free-radical scavengers, is pH dependent and occurs in the presence 
of some iron complexing agent. After oxidation, the first product observed was a lactone 
presumed responsible for the inhibition of -glucuronidase (Marsh, 1986). Accumulative 
evidence on the inhibition of -glucuronidase provided many researchers the knowledge 
to further investigate the role of GA in cancer prevention.  
2.8. D-glucaric acid and potential cancer prevention  
Several studies, reviewed in later sections, have termed dietary D-glucarate as a 
chemoprotective agent with strong supporting evidence. The chemopreventive property 
that has been linked to D-glucarate is due to the ability of this compound to affect the 
overall efficiency of phase II enzyme UGP-glucuronosyltranferase (UDPGT) by 
preventing de-glucuronidation.  It has been hypothesized by many studies that by 
modulating the activity of -glucuronidase the net glucuronidation is increased, leading 
to the efficient removal of toxins, carcinogens, and other carcinogenic substances. In 
1952, Levvy published that 1,4-GL is a potent inhibitor of  mammalian -glucuronidase 
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(Levvy, 1952). Later studies showed that -glucuronidase was higher in patients with 
bladder cancer (Boyland, Gasson, & Williams, 1957). These results plus the fact that 
1,4-GL shortened the pharmacologic action of drugs (Marselos, Dutton, & Hanninen, 
1975), lead to theory that GA or its derivatives could be used as chemopreventive agents.  
The inhibition of -glucuronidase by 1,4-GL was also observed to repress marker 
oncofetal protein, which has been observed to be correlated with the appearance of pre-
neoplastic foci (Walaszek, Hanausek-Walaszek, & Webb, 1988). 
 Fruits and vegetables have been reported to contain high levels of D-glucarate 
(Walaszek, Szemraj, Hanausek, Adams, & Sherman, 1996; Dwivedi, Heck, Downie, 
Larroya, & Webb, 1990). In both the of these studies, various fruits and vegetables were 
examined using several of the previously described methods for the evaluation of GA. 
Interestingly, in both studies citrus fruits reported the highest values. Since previous 
studies have evaluated the oral administration of GA in animals and the presence of GA 
in fruits and vegetables, the concept of GA acquisition by dietary means for cancer 
prevention was proposed. It was later, shown that the inhibitory 1,4-GL was formed in 
the acidic conditions of the stomach, when GA salt was orally administered (Walaszek 
et al., 1997).  Furthermore, it was also shown that 1,4-GL was absorbed through the 
intestine, transported within the blood to different organs, and finally excreted in urine. 
Reports on the effect of GA on detoxification and its presence in fruits and vegetables, 
enticed researchers to investigate the correlation between plant-food intake and levels of 
serum -glucuronidase (Lampe, Li, Potter, & King, 2002). This study reported an 
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inverse association with the consumption of plant-food and -glucuronidase levels, 
suggesting the possibility of enhancing physiological well being by dietary means.  
GA has proven to be effective in the prevention if various types of cancer, but 
overall, breast cancer has been the most studied. Initial studies showed, that 1,4-GL 
exhibited a 70% reduction in the number of rats with mammary tumors induced by 7,12-
dimethylbenzanthracene (DMBA), 72% decrease in the number of  mammary tumors 
per rat, and a reduction in the induction of oncofetal proteins (Walaszek, Hanausek-
Walaszek, & Webb, 1984). Using the same model, further reports on the use of calcium 
D-glucarate for the prevention of mammary tumorigenesis were published (Walaszek, 
Hanausek-Walaszek, Minton, & Webb, 1986). In a later study, rats fed GA for 2-4 
weeks showed inhibited -glucuronidase activities leading to a marked antiproliferative 
effect in mammary epithelium tissue (Walaszek, Hanausek, Sherman, & Adams, 1990). 
Furthermore, When GA and N-(4-hydroxyphenyl) retinamide were administered 
independently a 50-65% inhibition of tumor incidence and tumor multiplicity was 
observed, similar observations were noted when a combination of GA and N-(4-
hydroxyphenyl) retinamide was administered (Abou-Issa, Duruibe, Minton, Larroya, 
Dwivedi, & Webb, 1988).  Additionally, It was later shown that N-(4-hydroxyphenyl) 
retinamide used in combination with GA suppressed the growth of MCF-7 human breast 
cancer cells in vitro (Bhatnagar, Abou-Issa, Curley, Koolemans-Beynan, Moeschberger, 
& Webb, 1991). It was later reported that the basis for the chemopreventive properties of 
these compounds used individually and/or in combination is that they raise cellular 
cAMP levels, repress protein kinase C and inhibit DNA synthesis (Abou-Issa et al., 
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1993). Furthermore, it was later demonstrated that when GA or N-(4-hydroxyphenyl) 
retinamide were administered during the promotion phase of DMBA induced 
tumorigenesis, there was increased tumor latency while tumor multiplicity was 
decreased (Abou-Issa, 1995). In addition, it was also observed that when fed during 
initiation or promotion separately or throughout both phased continually, GA and N-(4-
hydroxyphenyl) retinamide were observed to reduce tumor incidence compared to the 
control. 
 Besides breast cancer, the effects of GA on other types of cancer has also been 
previously studied.  GA was initially tested for chemopreventive properties against 
bladder cancer (Boyland, Wallace, Avis, & Kinder, 1964; Boyland, Kinder, Manson, & 
Wallace, 1965). Additionally, the role of GA on colon cancer was also explored (Takada, 
Hirooka, Hiramatsu, & Yamamoto, 1982; Dwivedi, Oredipe, Barth, Downie, & Webb, 
1989; Yoshimi, Walaszek, Mori, Hansusek, Szenraj, & Slaga, 2000). Chemopreventive 
properties of GA were also reported on skin, liver and lung cancer (Dwivedi, Downie, & 
Webb; 1989; Gupta & Singh, 2004; Walaszek, Hanausek, Narog, Zoltaszek, & Slaga 
2005; Oredipe, Barth, Hanausek-Walaszek, Sautins, Walaszek, & Webb, 1987; Oredipe, 
Barth, Dwivedi, & Webb, 1992; Walaszek, Hanausek, Zoltaszek & Slaga, 2004; 
Hanausek, Walaszek, Szemraj, Zoltaszek, & Slaga, 2004). Interestingly, phase I clinical 
trials initiated by Walaszek, Hanausek, Narog, Raich, & Slaga (2004) found that 
increased doses of GA consistently suppressed -glucuronidase levels and that at highest 
concentrations calcium D-glucarate was well tolerated with no signs of toxicity.      
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2.10. Analytical methods for D-glucaric acid 
 Early research demonstrated that GA was found in urine and that its precursor, 
1,4-GL, was a potent -glucuronidase inhibitor. These findings led to a need to 
quantitatively determine the amount of GA in bodily fluid, mainly urine and blood 
serum. A quantitative method for the determination of GA in urine was initially reported 
by Marsh & Reid in 1963. This method consisted of boiling of GA to yield the highly 
specific -glucuronidase inhibitor 1,4-GL. A later study by a group of Japanese 
scientists reported that, even though 1,4-GL is highly specific, many other compounds 
present in urine also inhibit  -glucuronidase activity (Ishidate, Matsui, & Okada, 1965).  
In this study, quantification of GA using chemical determination was achieved which 
involved the treatment of urine with ion exchange chromatography, then the eluate was 
oxidized with periodic acid and the product was subjected to colorimetric determination. 
In later investigations, a method was developed using gas-liquid chromatography of the 
silylated derivatives of GA, but in this study GA was determined to the 0.1g level 
(Gangolli, Longland, & Shilling, 1974). In a study analyzing lactone-forming acid in 
succulent plants, thin layered chromatography was employed to identify GA content of 
the plants. This method involved the isolation of the acid from the plant material, 
pretreatment of the TLC plate with a mixture of solvents, detection by either UV light or 
Hydroxylamine-ferric chloride and bromophenol blue, and finally heating for one hour 
at 105°C (Kringstad & Nordal, 1975). While new methods were emerging, Marsh’s 
1963 method was still the most widely used to evaluate the GA content in urine and 
serum. Several investigations were published from 1965-1977 citing this method (Aarts, 
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1965; Hunter, Maxwell, & Williams, 1971; Davidson, McIntosh, & Ford, 1974; Latham, 
1974; Smith & Rawlins, 1974; Herzberg, Tenenbaum, Fishel, & Wiener, 1977; 
Simmons, Davis, Dordoni, & Williams, 1974; March, Turner, Shanley, & Field, 1974). 
Thereafter, a new method was proposed that permitted the determination of GA with a 
linear calibration curve over a wide range versus the logarithmic calibration curve 
proposed by Marsh (Jung, Scholz, & Schreiber, 1981).  Unfortunately, the previously 
published methods were laborious and in many instances lacking reproducibility and 
accuracy. In 1983, a new low-pH method was proposed by a group of Italian scientists. 
Using the knowledge of the equilibrium of GA and its lactones in solution, Marsh’s 
enzymatic method was evaluated at various pH and found that by boiling GA at pH 3.8 
inhibition of -glucuronidase was greater. This change in pH allows the GA/lactone 
equilibrium to remain constant during the enzymatic assay (Colombi, Maroni, Antonini, 
Cassina, Gambini, & Foa, 1983). Interestingly, during the same year, two other methods 
were published describing use of high performance liquid chromatography (HPLC). 
While one of these HPLC methods combined the use of ion exchange chromatography, 
radioactivity monitoring, and UV absorption in urine (Walters, Lake, Bayley, & Cottrell, 
1983), the other method described the separation of GA and its lactones from an aqueous 
solution (Laakso, Tokola, & Hirvisalo, 1983). Unfortunately, separation of GA was not 
effective enough to quantitatively determine the amount of GA present in urine from the 
previous methods. 
 In the mid 1980’s Marsh’s enzymatic method was still the most widely used 
method for the determination of GA in urine. Over time, the method was continually 
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modified for higher repeatability and ease. In 1984, Marsh’s method was again 
optimized into a micro-method. The optimization is on the amount of samples that can 
be processed by a person per day, from 50 to 60 determinations in one day (Jung & 
Pergrande, 1984). Both enzymatic and chemical methods had advantages and 
disadvantages. In 1985 Marsh developed an enzymatic method for the determination of 
GA by converting it to pyruvate (Marsh, 1985). The theory behind this method is that 
GA, as a substrate for a dehydratase present in several bacteria, produces a mixture of 
glucarate derivatives that are then converted to pyruvic acid and tartronic acid by an 
aldolase enzyme. Since the measurement of pyruvic acid is a common practice, it 
seemed to be adequate for the spectrophotometric determination of GA.   
 The most prevalent methods for the determination of GA seemed to be the 
enzymatic method and the glycoxylic acid method.  While comparing the results of these 
methods, it was observed that the enzymatic method is preferable.  The enzymatic 
method is less subject to interference and less labor intensive compared to the glyoxylic 
acid method (Steinberg & Needham, 1986). Furthermore, a new method was proposed 
by Paolo Mocaraelli in 1988, which averaged about 100 determinations per day and still 
retained the precision and accuracy of previous enzymatic methods, with the added 
bonus of being suitable for automated instruments (Mocaraelli et al., 1988). This new 
method made the process more adequate for use in clinical settings. In 1993, a simple 
HPLC method for the determination of GA in urine was proposed (Poon, Villenueve, 
Chu, & Kinach, 1993).  This simple isocratic HPLC method consisted of the treatment 
of urine with a gel that has a high affinity for GA, separating it from other substances.  
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Interestingly, in 1998, a group of cancer researchers reinforced the use of the pyruvate 
assay for the analysis of blood serum of breast and prostate cancer patients.  The authors 
stated that the uses of other methods are not as sensitive for the quantification of GA as 
the pyruvate method (Walaszek, Hanausek, Szemraj, & Adams, 1998). 
 Due to increase in cancer incidence and the fact that previous studies correlate 
the consumption of dietary GA and cancer prevention, two studies were published 
concerning the content of GA in food. The presence of GA in plants has previously been 
reported (Kringstad & Nordal, 1975; Risch, Herrmann, & Wray, 1988).  In 1990, a study 
evaluated the effect of GA on -glucuronidase activity and the GA content in fruits and 
vegetables (Dwivedi, Heck, Downie, Larroya, & Webb, 1990).  The fruits and 
vegetables were analyzed by the enzyme inhibition method and confirmed by HPLC. 
The results of this study indicated that orange contained the highest levels of GA 
(4.64mg/100g), followed by spinach, apples, carrot, alfalfa sprouts potatoes and broccoli. 
Later, researchers form MD Anderson Cancer Center, reevaluated the GA content of 
various fruits and vegetables and analyzed the cholesterol lowering effects of GA in rats 
(Walaszek, Szemraj, Hanausek, Adams, & Sherman, 1996).  In this study, both the 
enzymatic and the pyruvate method were used  and found that grapefruit and apple had 
the highest levels of glucarate, 3.60 and 3.45 g/kg respectively, while in vegetables 
edible cactus and alfalfa sprouts contain high GA levels 3.49 and 3.45 g/kg, respectively.  
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CHAPTER III 
 
ORGAN SPECIFIC INDUCTION OF PHASE II ENZYMES BY CITRUS 
LIMONOIDS IN MOUSE 
 
 
3.1. Synopsis 
 Several cell culture and animal studies demonstrated that citrus limonoids have 
protective effects against certain types of cancer. These chemopreventive properties of 
citrus limonoids are believed to be attributed to the induction of phase II enzymes, in 
particular, glutathione S-transferase (GST). In the current study, the inductive effects of 
purified limonoids and their mixture have been investigated for GST and NAD(P)H: 
quinone reductase (QR) activities. Female A/J mice were treated with different citrus 
limonoids. Among the limonoids tested, the highest induction of GST against 1-chloro-
2,4-dinitrobenzene (CDNB) was observed in stomach, 58% by nomilin, followed by 
isoobacunoic acid (25%) and deacetylnomilin (19%). Deacetlylnomilin in intestine as 
well as liver and a mixture of limonoids in liver demonstrated a significant reduction of 
GST activity against CDNB.  Furthermore, induction of GST against 4-nitroquinoline 1-
oxide (4NQO) differs for each limonoid.  Nomilin showed significant induction of GST 
in intestine (280%) and stomach (75%) while deacetylnomilin showed significant 
induction only in intestine (73%) compared to control. Furthermore, a limonoid mixture 
significantly induced GST activity in intestine (93%) and stomach (45%). Finally, 
significant induction of QR activity was observed by isoobacunoic acid in liver (230%) 
followed by a limonoid mixture in stomach (200%) and deacetylnomilin in intestine 
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(22%).  While limonoids statistically induced both GST and QR activity (p<0.05) in 
specific organs, certain limonoids also showed a reduction of these phase II enzyme 
activities. Our findings indicate that the structural differences in the limonoids may 
provide specificity for induction or reduction of phase II enzyme activity. This kind of 
organ specificity related to the structural differences of limonoids indicates potential of 
these compounds in prevention of cancer.  Dietary intake of citrus limonoids may 
provide a powerful tool against the onset of various cancers. 
3.2 Introduction 
Citrus is the most widely consumed fruits in the world and found to possess 
important beneficial effects on human health.  Citrus fruits have long been recognized to 
contain secondary metabolites including flavonoids, vitamin C, furocoumarins, 
carotenoids, folate, pectin, and limonoids (Manners, Jacob, Breska, Schoch, & 
Hasegawa, 2003). Limonoids are a group of chemically related triterpene derivatives. 
Many studies conducted in our laboratory and elsewhere, using limonoids, provided 
evidence of their protective properties in cancer prevention and cardiovascular diseases 
(Miller, Porter, Binnie, Guo, & Hasegawa, 2004; Kurowska, Hasegawa, & Manners, 
2000a; Battinelli et al., 2003; Miyagi, Om, Chee, & Bennink, 2000; Tanaka et al., 2000; 
Vanamala et al., 2006; Miller, Fanous, Rivera-Hidalgo, Binnie, Hasegawa, & Lam, 
1989). Citrus limonoids have been reported to lower cholesterol by reducing the 
production of  medium apo B as seen in cultured human liver cells HepG2 (Kurowska, 
Hasegawa, & Manners, 2000a). Two citrus limonoids (limonin and nomilin) have been 
evaluated for their ability of inhibiting HIV-1 replication (Battinelli et al., 2003). During 
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the last decade, the health maintaining properties of citrus limonoids has been focused in 
anti-cancer properties using cell and animal models. In two Japanese studies, it was 
reported that orange juice and citrus limonoids, obacunone and limonin, played an 
important role in the inhibition of azoxymethane-induced colon cancer (Miyagi, Om, 
Chee, & Bennink, 2000; Tanaka et al., 2000). A recent study provided evidence that 
limonin, naringin, and whole grapefruit protect against azoxymethane (AOM) induced 
aberrant crypt foci (Vanamala et al., 2006). Inhibition of 7,12-
dimethylbenz[a]anthracene- induced oral tumors by citrus limonoids has been the focus 
in our collaboration efforts (Miller, Porter, Binnie, Guo, & Hasegawa, 2004; Miller, 
Fanous, Rivera-Hidalgo, Binnie, Hasegawa, & Lam, 1989). Additionally, 
benzo[a]pyrene induced forestomach neoplasia in mice was inhibited by citrus 
limonoids (Lam & Hasegawa, 1989).  
 Recently cell culture studies from our laboratory have investigated the effects of 
citrus limonoids (Poulose, Harris & Patil, 2005; Poulose, Harris, & Patil, 2006; Tian, 
Miller, Ahmad, Tang, & Patil, 2001).  In one study, citrus limonoid glucosides were 
proven to be lethal at micromolar concentrations for neuroblastoma cells in culture 
(Poulose, Harris & Patil, 2005). Furthermore, limonoid aglycones were shown to 
significantly reduce viability of SH-SY5Y neuroblastoma and Caco-2 colonic 
adenocarcinoma. The non-cancerous Chinese hamster ovary cells hardly showed any 
change in cell numbers or morphology when treated with the limonoids (Poulose, Harris, 
& Patil, 2006). Additionally, reports from our laboratory showed that the cytotoxic 
  
29 
 
effect of the specific limonoids tested on MCF-7 cells may have an effect limited to 
breast cancer cells (Tian, Miller, Ahmad, Tang, & Patil, 2001).   
    Over the past two decades, several articles have reported isolation of citrus 
limonoids from seeds, peels, fruit, juice and other by-products (Rouseff & Nagy, 1982; 
Bennet, Hasegawa, & Herman, 1989; Miyake, Ozaki, Ayano, Bennett, Herman, & 
Hasegawa, 1992; Ohta, Berhow, Bennett, & Hasegawa, 1992; Berhow, Omura, Ohta, 
Ozaki, & Hasegawa, 1994; Ozaki, Ayan, Inaba, Miyake, Berhow, & Hasegawa, 1995). 
Recently, more efficient methods have been reported for isolating a variety of limonoids, 
aglycones and glucosides, from citrus (Jayaprakasha, Brodbelt, Bhat, & Patil, 2006a; 
Raman, Cho, Brodbelt, & Patil, 2005; Jayaprakasha, Patil, & Bhat, 2006b). Limonoid 
glucosides are tasteless water soluble compounds formed in fruits during maturation 
from their corresponding aglycones. On the other hand, certain aglycones are bitter with 
low water solubility and principally found in seeds (Hasegawa, 2000). Citrus limonoids 
contain a furan moiety attached to the D-ring lactone at the 3- position. Studies on furan-
containing natural products have suggested that the furan moiety is responsible for the 
induction of the phase II detoxifying enzyme glutathione S- transferase (GST) (Tian, 
Miller, Ahmad, Tang, & Patil, 2001). In 2003, Kelly, Jewell, & O’Brien reported an 
induction of GST activity when rats were fed limonin and nomilin. Potential induction 
of phase II enzymes, such as GST, using naturally occurring compounds has sparked an 
interest in the scientific community. 
 Gluthathione S-transferases are thought to play a crucial physiological role in the 
initial stages of detoxification of potential alkylating agents (Booth, Boyland, & Sims, 
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1961). An increase in the activity of GST usually enhances the ability of an organism to 
detoxify carcinogens. It has been reported that substances that increases the activity of 
GST can be a potential anti-carcinogen with the ability to inhibit chemically induced 
cancer formation (Lam, Li, & Hasegawa, 1989) Another phase II enzyme, which is also 
important in the protection against toxic and neoplastic effects of xenobiotics, is 
NAD(P)H: quinone reductase (QR). QR protects against cytotoxicity by catalysing the 
two electron reduction of quinones that arise from a one electron reduction. An increase 
in its level is positively correlated with chemoprevention (Benson, Hunkeler, & Talalay, 
1980). Previous cell culture studies demonstrated that freeze dried grapefruit extracts 
induce both GST and QR activities (Williamson et al., 1997).  A recent study also 
demonstrated that the consumption of citrus fruits modulate both phase I and phase II 
metabolizing enzymes in rats (Hahn-Obercyger, Stark, & Madar, 2005).  
Accumulating evidence suggest that certain citrus limonoids have the ability to 
induce detoxifying enzymes, mainly GST (Tanaka et al., 2000; Miller, Fanous, Rivera-
Hidalgo, Binnie, Hasegawa, & Lam, 1989; Lam & Hasegawa, 1989, Kelly, Jewell, & 
O’Brien, 2003; Lam, Li, & Hasegawa, 1989; Ahmad, Li, Polson, Makie, Quiroga, & 
Patil, 2006). In majority of these studies nomilin has proven to be the strongest inducer 
of GST activity against CDNB. While evaluating the induction of GST activity, CDNB 
is used as a general substrate, without exhibiting any substrate preference in GST 
isozymes , ,  (Ahmad, Tijerina, & Tobola, 1997).  A later study showed that the 
specific activity of the , ,  isozymes varied widely when CDNB was used as a 
substrate (Townsend, Fields, Doss, Clapper, Doehmer, & Morrow, 1998). One study 
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suggests that the GST  isozyme is more efficient in the conjugation of 4NQO (Aceto, 
Llio, Lo Bello, Bucciarelli, Angelucci, & Federici, 1990). Most major mammalian GST 
isozymes are grouped into four major classes namely, , ,  and  (Mannervik & 
Danielson, 1988; Meyer, Coles, Pemble, Glimore, Fraser, & Ketterer, 1991). Due to the 
significant variability of GST isozymes in different tissues, it is important to evaluate the 
induction capabilities of citrus limonoids using substrate models other than CDNB.  
In order to understand the role of the A and A’ rings in the limonoids on 
biological activity, we analyzed the induction potential of specific citrus limonoids (fig. 
2) with a closed A ring (nomilin, deacetylnomilin) and open A ring (isoobacunoic acid).  
Previous research suggest that modifications to the A and A’ rings have significant 
differences in the ability to induce GST activity (Lam, Li, & Hasegawa, 1989). For 
example, ichangin with a closed A ring and an open A’ring, showed induction of GST 
activity (Lam, Li, & Hasegawa, 1989). The understanding of the relationship between 
the various structural properties of citrus limonoids and induction of phase II detoxifying 
enzymes is vital for cancer prevention. In this study, we intend to further elucidate the 
function of various structurally dissimilar citrus limonoids in the induction of phase II 
enzymes, GST and QR.  
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3.3.  Materials and methods 
3.3.1. Materials 
 All solvents / chemicals used in this study were obtained from Fisher Scientific 
(Houston, TX). β-NADPH reduced tetrasodium salt, 2,6-dichlorophenol-indophenol 
(DCPIP), 1-chloro-2,4-dinitrobenzene (CDNB), 4-nitroquinoline 1-oxide (4NQO),  
glutathione reduced (GSH), FAD disodium salt, and all solvents were purchased from 
Sigma-Aldrich company (St. Louis, MO). Bovine Serum Albumin (BSA) was obtained 
from Intergen (Purchase, NY). The citrus limonoids used in this investigation were 
isolated and purified in our laboratory. 
3.3.2. Animal studies 
 Female A/JOlaHsd 8-9 weeks old mice were purchased from Harlan Sprague-
Dawley Laboratory (Indianapolis, IN).  The mice were kept on AIN-76 semi-purified 
custom diet without vitamin E obtained from MPBiomedical (Solon, OH) and tap water 
ad libitum. The mice were housed in plastic cages in an environmentally controlled 
room on a 12 h light / 12 h dark cycle.  
The mice were divided (n=4) into four experimental groups and one control 
group. The treatments consisted of nomilin, deacetylnomilin, isoobacunoic acid and a 
limonoid mixture (limonin, nomilin, and isoobacunoic acid). Each sample (20 mg) was 
suspended in DMSO: corn oil (1:1) (v/v) and administered by oral gavage once every 
two days. The control group was given the corresponding DMSO: corn oil (1:1) 
treatment. A total of four treatments were administered. Forty eight hours after the last 
treatment the mice were sacrificed by cervical dislocation.  Lung, intestine, stomach, and 
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liver were harvested immediately after sacrifice and washed with cold PBS. A portion of 
the tissue was stored for future use, while the remaining portion was weighed and 
homogenized using a Pro200 homogenizer with PBS (10mM), pH 7.0, containing β-
mercaptoethanol (1.4mM) to obtain a 10% (w/v) homogenate. The cell extracts were 
centrifuged at 22,000 x g for 45 min in a refrigerated Beckman Avanti 30 centrifuge. 
Following centrifugation, the supernatant was carefully removed and stored in -20°C 
until further use. 
3.3.3. Determination of enzyme activities and protein  
 GST activity against CDNB was determined by the slightly modified method 
developed by Habig, Pabst, & Jakoby (1974). This system involves the addition of GSH 
to CDNB, a nucleophilic aromatic substitution that occurs via an addition-elimination 
sequence involving a short lived -complex intermediate (Armstrong, 1997). The 1ml 
enzyme assay consisted of 100 mM phosphate assay buffer, pH 6.5; 20 mM CDNB and 
10 mM GSH and 50 µl of tissue homogenate sample. The absorbance was measured at 
340 nm in a Beckman DU 640 UV/Visible spectrophotometer against an appropriate 
blank. 
 GST activity against 4NQO was performed using a modified method developed 
by Stanley & Benson (1988). In this reaction the glutathione replaces the nitro group of 
4NQO. The 1ml enzyme assay consisted of 100 mM phosphate assay buffer pH 6.5; 5 
mM 4NQO and 10 mM GSH and 20 µl of tissue homogenate. The absorbance was 
measured at 350 nm in a Beckman DU 640 UV/ Visible spectrophotometer against an 
appropriate blank. 
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 The QR activity was determined by slight modification of the method reported 
by Wang, Liu, Higuchi, & Chen (1998). The 1ml enzyme assay system consisted of 25 
mM Tris/ HCl pH 7.5; 0.18 mg/ml BSA; 5 µM FAD; 0.2 mM NAD(P)H; 40 µM DCPIP 
and 20 µl of tissue homogenate. The blank contained all the above except the tissue 
homogenate and 0.2 mM NAD(P)H, while the control contained all except the enzyme 
sample. The absorbance was measured at 600 nm in a Beckman DU 640 UV/Visible 
spectrophotometer against the blank.  
 The spectrophotometer was equipped with enzyme kinetic software and 
programmed to calculate enzyme units. The amount of enzyme that used 1 mole of 
substrate per minute at 25°C is equivalent to one unit of enzyme activity.  Each organ 
homogenate represented one sample; all assays were performed in triplicates. Student’s 
t-test was used to asses the significance of the data.  
The protein content of the samples was quantified by Bradford’s method (1976). 
The absorbance was read at 595 nm. Bovine serum albumin was used as a standard. 
3. 4.  Results 
 The effect of three limonoids and the mixture of limonoids was investigated on 
four organs of female A/J on the induction of GST activity (Table 1). Among the 
limonoids tested, the highest induction of GST was observed against CDNB by nomilin 
(58%), followed by isoobacunoic acid (25%) and deacetylnomilin (19%) in stomach.  
Interestingly, deacetlylnomilin in intestine as well as in liver and the mixture of 
limonoids in liver demonstrated significant inhibition of GST against CDNB. On the 
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contrary, no significant changes were observed in any of the treatment groups in lung 
homogenates. 
Furthermore, GST activity was measured against 4NQO, in four organs 
mentioned earlier and the results are presented in Fig.3.  The most noticeable induction 
of GST activity against 4NQO, was observed in intestine homogenates compared to 
control.  Nomilin showed significant induction of GST in intestine (280%) and in 
stomach (75%) while the limonoid mixture (93%) and deacetylnomilin (73%) 
significantly induced GST activity in intestine homogenates. In stomach homogenates, 
nomilin (75%) and the limonoid mixture (45%) significantly (p<0.05) induced GST 
activity against 4NQO. Although not statistically significant, an increase in activity was 
also observed due to deacetylnomilin and isoobacunoic acid. In the other organs, lung 
and liver, no significant GST activity was observed. Interestingly, deacetlylnomilin in 
intestine as well as liver and the mixture of limonoids in liver demonstrated significant 
reduction of GST activity against CDNB.  
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      Table 1 
      GST Activity against 1-chloro-2,4-dinitrobenzene, CDNB (Specific activity expressed as units/mg protein) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results are means ±SD (n=4) 
a
  indicates significant reduction of activity at p<0.05  
** indicates significant induction of activity at p<0.05  
Samples Stomach Intestine Liver  Lung 
Control 
 
0.728 ± 0.05 1.260 ± 0.13 2.520 ± 0.11 0.399 ± 0.07 
Mixture 
 
0.757 ± 0.02 1.191 ± 0.11 1.833 ± 0.26 a 0.414 ± 0.02 
Nomilin 
 
1.152 ± 0.16** 1.122 ± 0.24 2.223 ± 0.39 0.395 ± 0.01 
Deacetylnomilin 
 
0.872 ± 0.09** 0.715 ± 0.18 a 1.582 ± 0.24 a 0.449 ± 0.01 
Isoobacunoic Acid 
 
0.914 ± 0.13** 0.825 ± 0.84 1.390 ± 0.02 0.365 ± 0.01 
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Fig. 3. GST activity in different organ homogenates against 4-NQO. Bars indicate mean ± S.D. (n=4). 
 ** indicate significant induction (p<0.05).  
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Table 2 depicts QR activity in liver, intestine, lung and stomach homogenates. In 
stomach homogenates, significant induction of QR activity was observed in the limonoid 
mixture (200%) treatment group. Deacetylnomilin (22%) treatment group showed 
induction of QR activity in intestine homogenates and isoobacunoic acid (23%) treatment 
groups showed induction in liver. Similar to GST, none of the limonoids significantly 
induced QR activity in lung homogenates.  Isoobacunoic acid, however, showed 
significant inhibition of QR activity compared to the control. 
           
 
 
 
Table 2 
Quinone reductase activity (Specific activity expressed as units/mg protein). 
           Results are means ± SD (n=4) 
a
  indicate significant reduction of QR activity was observed at p<0.05 
** indicate significant induction of QR activity was observed at p<0.05 
 
Samples Stomach Intestine Liver Lung 
Control 6.592 ± 0.60 3.838 ± 0.54 0.618 ± 0.06 0.377 ± 0.12 
 
Mixture 13.372 ± 4.17** 3.544 ± 0.92 0.623 ± 0.10 0.374 ± 0.05 
 
Nomilin 6.226 ± 0. 71 2.892 ± 0.43 0.662 ± 0.17 0.354 ± 0.02 
 
Deacetylnomilin 6.113 ± 2.12  4.702 ± 0.43**  1.137 ± 0.36** 0.356 ± 0.04 
 
Isoobacunoic acid 4.982 ± 1.19 a 3.229 ± 2.57 1.477 ± 0.78** 0.349 ± 0.03 
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3.5. Discussion 
 Recent research has been focused on citrus limonoids, from their isolation to the 
elucidation of their structures, and the effects of these compounds on different biological 
systems (Miller, Porter, Binnie, Guo, & Hasegawa, 2004; Kurowska, Hasegawa, & 
Manners, 2000a; Battinelli et al., 2003; Miyagi, Om, Chee, & Bennink, 2000; Tanaka et 
al., 2000; Vanamala et al., 2006; Miller, Fanous, Rivera-Hidalgo, Binnie, Hasegawa, & 
Lam, 1989; Lam & Hasegawa, 1989; Poulose, Harris & Patil, 2005; Poulose, Harris, & 
Patil, 2006; Tian, Miller, Ahmad, Tang, & Patil, 2001; Jayaprakasha, Brodbelt, Bhat, & 
Patil, 2006; Raman, Cho, Brodbelt, & Patil, 2005; Jayaprakasha, Patil, & Bhat, 2006b).  
A major focus in citrus limonoid research has been on their ability to induce the activity 
of phase II detoxification enzymes, mainly GST. A recent study in the Netherlands, 
evaluated the effect of habitual consumption of fruits and vegetables on rectal GST 
activity against CDNB. It seems that consumption of fruits and vegetables was positively 
correlated with human rectal GST activity (Wark et al., 2004).  Several studies have 
attributed the induction of these enzymes to the structural components of limonoids. The 
furan moiety has been thought to be one of the components responsible for induction of 
GST activity (Lam, Li, & Hasegawa, 1989). Lam, Sparnins, & Wattenburg (1982) 
studied two furan containing diterpenes, kahweol and cafestol, which were shown to 
induce an increase in the activity GST in various tissues in mice. In a later study, eight 
citrus limonoids were tested for induction of GST activity in mice and the structural 
features of different citrus limonoids and their effect on GST activity has been reported. 
It seems glutathione S-transferase plays a crucial physiological role in the initial stages of 
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detoxification of potential alkylating agents (Booth, Boyland, & Sims, 1961). GST 
enzymes catalyze the adduct formation of glutathione (GSH), a tripeptide consisting of 
glycine, cysteine, and glutamic acid with electrophilic xenobiotics (Beutler, Duron, & 
Kelly, 1963). GST catalyzes the reaction of xenobiotic and other environmental factors to 
react with the –SH of glutathione, neutralizing the toxin and making it more water 
soluble (Armstrong, 1997). An increase in the activity of GST usually enhances the 
ability of an organism to detoxify carcinogens. Hence, it is possible that any substance 
that increases the activity of GST can be a potential anti-carcinogen with the ability to 
inhibit chemically induced cancer formation (Lam, Li, & Hasegawa, 1989). Other 
structural features that seem to play a role in the induction of GST activity are the A and 
A’ rings, and modification to the B ring in limonoids. The present study was conducted 
under controlled dietary conditions. Furthermore, a mixture of limonoids was also used in 
order to observe any increase of GST activity, possibly due to synergistic effect. 
 Quinone reductase activity has also been observed along with other phase II 
enzymes (De Long, Proshaska, & Talalay, 1986). QR protects against cytotoxicity, and 
an increase in its levels is positively correlated with chemoprevention. QR levels increase 
along with the levels of other chemopreventive enzymes and it is induced by several 
chemically dissimilar substances (De Long, Proshaska, & Talalay, 1986). QR catalyses 
the two electron reduction of quinones to protect cells from free radicals and reactive 
oxygen species that arise from a one electron reduction. Quinones are one of the toxic 
products of oxidative metabolism of aromatic hydrocarbons (Horning, Thenot, & Helton, 
1978). The reduction of quinones leads to their detoxification or to the production of 
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biologically reactive products depending upon the mechanism of reaction and subsequent 
deposition of hydroquinone products (Benson, Hunkeler, & Talalay, 1980). In a previous 
study, nimbolide, a limonoid isolated from neem flowers, showed induction of QR 
activity in Hepa1c1c7 cells (Sritanaudomchai et al., 2005).  
  In our study, nomilin, which is composed of intact A, B, C, and D rings showed the 
highest induction activity in the GST assays. It seems that, nomilin possesses most of the 
structural features that are reported to be essential in the induction of GST activity. 
Deacetylnomilin has a structural similarity to nomilin with the exception of the 
deacetylation of the A ring. Deacetylnomilin showed induction of GST in some organs, 
while also inducing QR activity in liver and intestine. These results reinforce our 
observations that the composition of the A ring is critical for the induction of phase II 
enzymes. 
Isoobacunoic acid has an intact A’ ring and an open A ring, while the rest of the 
limonoid structure is similar to nomilin. Induction of GST activity against CDNB was 
only observed in stomach homogenates. It is interesting that some induction of GST 
activity was observed even in the absence of an intact A ring. It is possible that other 
components of the limonoid structure may serve as a catalyst for enzyme induction. The 
limonoid mixture utilized showed induction of GST activity against 4NQO in stomach 
and liver homogenates and some induction of QR activity was observed in stomach 
homogenates. The limonoid mixture was composed of limonin, nomilin, and 
isoobacunoic acid. In a previous study (Lam, Li, & Hasegawa, 1989), it was concluded 
that limonin was ineffective as a GST inducer. This was attributed to the fact that the 
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structure of limonin is composed of intact A and A’ rings. In the current study, the ability 
of the limonoid mixture to induce GST activity was probably due to the presence of 
deacetylnomilin. Deacetylnomilin showed induction in many of the assays performed and 
could be responsible for the induction of GST activity even in the presence of limonin.  
 In this study an interesting observation was made, the limonoids tested were not 
active inducers of GST activity in lung. This phenomenon could be due to the fact that 
the composition of GST isoenzymes vary in mammalian tissues. Previous reports suggest 
that variability of GST isoenzymes is influenced by tissue, species, and gender (Mitchell, 
Morin, Lakritz, & Jones, 1997; Hu & Singh, 1997; Singh et al., 1998). Furthermore, it 
was also demonstrated that one of the GST isoenzymes in stomach is efficient in the 
conjugation of glutathione but was not detected in lung homogenate from A/J female 
mouse (Hu & Singh, 1997). Further studies suggested that the gender of the organism 
also influenced isoenzyme composition, in addition to GST differences among tissues 
(Singh et al., 1998). It is possible that the absence of induction of GST activity in lung by 
citrus limonoids may be due to the fact that the substrates utilized were not specific for 
GST isoenzymes in the mice tested. 
 In addition to the inactivity of limonoid in lung homogenates, certain limonoids 
reduced GST activity in different organs. Previous studies have shown that GST activity 
can be inhibited, reversibly and irreversibly by various compounds (Ploemen, Can 
Ommen, Hann, Schefferlie, & van Balderen, 1993). It has been proposed that possible 
inhibition mechanisms are the covalent bonding of compounds to the GST enzyme, 
competitive inhibition against CDNB, and noncompetitive inhibition against GSH 
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(Yamada & Kaplowitz, 1980; Ploemen, van Ommen, van Bladeren, 1990; Clark & 
Sinclair, 1988). Inhibition of GST enzyme could also be beneficial for chemotherapeutic 
reasons. The inhibition GST could prevent the possible inactivation of chemotherapeutic 
drugs (Black & Wolf 1991).  
3.6. Conclusion 
The ability of citrus limonoids to induce GST and QR activity renders them as 
potent anti-carcinogens. Further studies need to be conducted in order to truly understand 
the structural-activity relationship between citrus limonoids and certain phase II enzymes. 
From our present study, it seems possible that an adequate intake of citrus fruit may lead 
to a better ability of detoxification by these phase II enzymes in the body, which may 
have potential benefits in prevention of cancer and xenobiotic related diseases. To the 
best of our knowledge, this is the first to report on the induction QR and GST against 
4NQO by certain citrus limonoids. 
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CHAPTER IV 
 
LIMONIN METHOXYLATION INFLUENCES INDUCTION OF 
GLUTATHIONE S-TRANSFERASE AND NAD(P)H: QUINONE REDUCTASE 
 
 
 4.1. Synopsis 
Previous studies indicated that chemoprevention by citrus limonoids has been 
attributed to the induction of phase II detoxifying enzymes. In this study three purified 
and two modified limonoids were use to investigate the influence of Phase II enzymes 
NAD(P)H: quinone reductase (QR) and glutathione S-tranferase (GST) activities against 
CDNB and 4NQO in female A/J mice. Our results show that the highest induction (67%) 
of GST activity against CDNB was displayed by deacetyl nomilinic acid glucoside in 
lung homogenates followed by limonin-7-methoxime (32%) in treated liver homogenates. 
Interestingly, the limonin-7-methoxime showed the highest (270%) GST activity in liver 
against 4NQO, while the same compound in stomach induced GST by 51% compared to 
the control. The deacetyl nomilinic acid glucoside treatment group induced GST activity 
by 55% in stomach homogenates. Another Phase II enzyme, QR, was significantly 
induced by limonin-7-methoxime by 65 and 32% in liver and lung homogenates, 
respectively.  Modified limonoid, defuran limonin, induced QR in lung homogenates by 
45%. Our results indicate that modification to the functional groups of the limonin 
structure may differentially influence their ability to induce phase II enzyme activity. 
These findings are indicative of a possible mechanism for the prevention of cancer by 
aiding in detoxification of xenobiotics. 
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4.2. Introduction 
  
 Health maintaining properties citrus fruits have recently been promoted due to 
several cell culture and animal studies on cancer prevention. Recent research has 
transitioned from the study of classical vitamin deficiency related diseases such as scurvy 
to the study of thousands of bioactive compounds that may have important roles in 
prevention of several diseases such as cancer, heart and Alzheimer’s (Ejaz, Ejaz, Matsuda, 
& Lim, 2006).   Initial research on citrus limonoids was initiated to ameliorate the 
bitterness problem in citrus juice due to the bitter limonoid aglycones, limonin and 
nomilin (Miller, Porter, Binnie, Guo, & Hasegawa, 2004). 
 Limonoids are a group of structurally related triterpene derivatives found in plant 
families Rutaceae and Meliaceae (Hasegawa, Bennett, & Verdon, 1980). Citrus 
limonoids are composed of two main nucleus structures. The structure of limonin 
exemplifies the first general nucleus which consists of five rings designated A, A, B, C, 
and D.  The second limonoid structure, nomilin, consists of four rings designated as A, B, 
C, and D. 
 Several studies in our lab (Vanamala et al., 2006; Poulose, Harris & Patil, 2005; 
Poulose, Harris, & Patil, 2006; Tian, Miller, Ahmad, Tang, & Patil, 2001) and elsewhere 
(Kurowska, Hasegawa, & Manners, 2000a; Battinelli et al., 2003; Miyagi, Om, Chee, & 
Bennink, 2000; Tanaka et al., 2000; Miller, Fanous, Rivera-Hidalgo, Binnie, Hasegawa, 
& Lam, 1989) demonstrated the role of limonoids for potential health benefits. The 
biological activities have been reviewed in chapter IV.  
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Additionally, our laboratory has been isolating a variety of limonoids, aglycones 
and glucosides, from citrus (Jayaprakasha, Brodbelt, Bhat, & Patil, 2006 a; Raman, Cho, 
Brodbelt, & Patil, 2005; Jayaprakasha, Patil, & Bhat, 2006b). Limonoid glucosides are 
tasteless water soluble compounds formed in fruits during maturation from their 
corresponding aglycones. Certain aglycones, on the other hand, are bitter compounds 
with low water solubility and principally found in seeds (Hasegawa, 2000). Naturally 
occurring citrus limonoids contain a furan ring attached to the D ring at the 3-position. 
The presence of the furan moiety is thought to be responsible for the induction of the 
phase II detoxifying enzyme GST activity. In addition to GST, another important phase II 
enzyme which protects against toxic and neoplastic effects of xenobiotics is QR. QR 
protects against cytotoxicity and increases in its levels are positively correlated with 
chemoprevention (De Long, Prosjaska, & Talalay, 1986). Recent research suggest that 
the consumption of citrus fruits, specifically grapefruit and oroblanco, modulate both 
phase I and phase II metabolizing enzymes in rats (Hahn-Obercyger, Stark, & Madar, 
2005). 
 In addition to chemoprevention, the phase II detoxification enzymes have also 
been reported to be involved in the aging process. According to the “free radical theory of 
aging”, the generation of free radicals play an important role in the aging process 
(Harman, 1956). Aerobic metabolism produces free radicals that accumulate over time. 
The accumulation of free radicals cause DNA, lipid and protein damage, which are 
continuously repaired by the body. Furthermore, the repair activity has been observed to 
decline with age (Valko, Leibfritz, Moncol, Cronin, Mazur, & Telser, 2007). It has been 
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observed that glutathione, glutathione related enzymes and other phase II enzymes 
protect cellular macromolecules from electrophilic attack by endogenous and exogenous 
substances. Previous research data suggest that the production of glutathione and 
glutathione utilizing enzyme activity decrease with age (Zhou, Gao, Cai, & Sparrow, 
2006), which may be creating an imbalance in the redox status. Levels of glutathione and 
glutathione metabolizing enzymes have been observed to remain constant when calorie 
restriction was administered as opposed to ad libitum diet, which displayed a decrease of 
glutathione and its enzymes with age (Cho et al., 2003).  
 Previous findings have reported the induction of phase II enzymes by a few citrus 
limonoids (Tian, Miller, Ahmad, Tang, & Patil, 2001; Miyagi, Om, Chee, & Bennink, 
2000; Tanaka et al., 2000; Lam, Li, & Hasegawa, 1989; Kelly, Jewell, & Brien, 2003; 
Ahmad, Li, Polson, Mackie, Quiroga, & Patil, 2006).  In these studies, GST activity was 
tested against CDNB, which is a commonly used substrate for a variety of GST isozymes 
(Ahmad, Tijerina, & Tobola, 1997). A previous study suggests that the  GST isozyme 
optimally conjugates 4NQO (Aceto, Llio, Lo Bello, Bucciarelli, Angelucci, & Federici, 
1990).  Most of the isozymes of GST found in mammalian tissues are grouped under four 
major classes namely , ,  and  (Mannervik & Danielson, 1988; Meyer, Coles, 
Pemble, Gilmore, Fraser, & Ketterer, 1991).  Due to the variability of these enzymes in 
different mammalian tissues, it is important to explore how citrus limonoids affect the 
activity of GST enzymes.    
 In the present study, we analyzed the induction of phase II detoxification enzymes, 
GST and QR using citrus limonoids purified from Citrus aurantium seed. In addition, 
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modified citrus limonoids were also used to further demonstrate the structural-activity 
relationship between the structurally different bioactive compounds and phase II 
enzymatic activity. 
4.3. Materials and methods 
 4.3.1.Materials 
 β-NADPH reduced tetrasodium salt, 2,6-dichlorophenol-indophenol (DCPIP), 1-
chloro-2,4-dinitrobenzene (CDNB), 4-nitroquinoline 1-oxide (4NQO),  glutathione 
reduced (GSH), FAD disodium salt, and all solvents were purchased from Sigma-Aldrich 
company (St. Louis, MO). Bovine Serum Albumin (BSA) was obtained from Intergen 
(Purchase, NY). Citrus limonoids used in this study were isolated and purified in our 
laboratory. Two limonoids limonin-7-methoxime and defuran limonin were modified 
according to established methods. The structures of these compounds are presented in 
figure 4. 
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Fig.4. Structures of purified and modified limonoids
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  4.3.2. Animals 
 Female A/J 8-9 weeks old mice were purchased from Harlen Sprague-Dawley 
Laboratory (Indianapolis, IN).  The mice were kept on a AIN-76 semi-purified custom 
diet without vitamin E obtained from MPBiomedical (Solon, OH) and tap water ad 
libitum. The mice were housed in plastic cages with “Aspen” Sani-chip bedding in an 
environmentally controlled room on a 12 h light / 12 h dark cycle.  
4.3.3. Experimental design and treatment 
 The mice were divided (n=4) into five experimental groups and one control 
group. The treatments consisted of limonin, limonin glucoside, deacetyl nomilinic acid 
glucoside, limonin-7-methoxime, and defuran limonin. Each limonoid treatment (20 mg) 
was suspended in DMSO: corn oil (1:1) (v/v) and the control group was given the 
corresponding DMSO: corn oil (1:1) treatment. The treatments were administered by 
oral gavage once every 48h. and a  total of four administrations were applied. Forty eight 
hours after the last treatment the mice were sacrificed by cervical dislocation. 
4.3.4. Preparation of organ samples 
 Lung, intestine, stomach, and liver were harvested immediately after sacrifice 
and washed with cold PBS. A portion of the tissue was separated for storage while the 
remaining was weighed and homogenized by a Pro200 homogenizer in 10% (w/v) PBS 
(10mM), pH 7.0, containing β-mercaptoethanol (1.4mM). Homogenates were 
centrifuged at 22,000 x g in a Beckman Avanti 30 centrifuge for 45 min. After 
centrifugation, the supernatant was carefully removed and stored in -20°C until further 
use. 
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4.3.5. Protein assay 
Cytosolic protein concentration was measured by Bradford’s quantification 
method (1976). Bovine serum albumin was used as a standard. 
 4.3.6. GST  assays 
 GST activities against 4NQO and CDNB were determined by a methods 
developed by Stanley et al. (1988) and Habig et al. (1974). The absorbance was 
monitored at 350 (4NQO) and 340 (CDNB) nm in a Beckman DU 640 UV/Visible 
spectrophotometer. The spectrophotometers were equipped with enzyme kinetic 
software and programmed to calculate enzyme units. The amount of enzyme that uses 1 
mole of substrate per minute at 25°C is equivalent to one unit of enzyme activity. 
4.3.7. QR assay  
The quinone oxidoreductase (QR) assay was performed by modifying a method 
reported by Wang et al. (1998), using DCPIP as substrate. The absorbance was 
measured at 600 nm in a Beckman DU 640 UV/Visible spectrophotometer. The 
spectrophotometers were equipped with enzyme kinetic software and programmed to 
calculate enzyme units. The amount of enzyme that used 1 mole of substrate per 
minute at 25°C is equivalent to one unit of enzyme activity. 
   Each organ homogenate representing one sample and all assays were 
performed in triplicates. Student’s t-test was used to asses the significance of the data 
obtained.  
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4.4. Results 
  Three purified citrus limonoids and two modified limonoids were tested for 
induction of phase II enzymatic activity. GST activities were assayed using CDNB and 
4NQO as substrates. Induction of QR was also evaluated.  
Mice were treated with the five limonoids in order to evaluate the induction of 
GST activity against CDNB. In lung, deacetyl nomilinic acid glucoside was the only 
limonoid that showed significant induction of GST activity, 67%, compared to the 
control.  Interestingly, in liver, modified methoxylated limonin-7-methoxime showed 
significant induction of GST activity, while limonin glucoside and deacetyl nomilinic 
acid glucoside showed slight reduction of activity (Table 3).  
GST activity was also measured against 4NQO. In stomach homogenates, 
deacetyl nomilinic acid glucoside (55%) showed the highest induction of GST activity, 
followed by limonin-7-methoxime (51%). In liver homogenates, limonin-7-methoxime 
induced GST activity was three times higher (270%) than that of the control. In intestine 
homogenates, defuran limonin and deacetyl nomilinic acid glucoside reduced GST 
activity, while no activity change was observed in lung homogenates (Fig 5). 
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             Table 3 
                             GST activity† against 1-chloro-2,4-dinitrobenzene 
Sample Stomach Intestine Liver  Lung 
Control 0.887  ± 0.07 0.864 ±0.09 1.783 ± 0.02 0.365 ± 0.08 
Limonin 0.837  ± 0.13 0.635 ± 0.01a 1.633 ± 0.27 0.342 ± 0.05 
Limonin-7-
methoxime 
 
0.898 ± 0.18 1.346 ± 0.47 2.367 ± 0.05** 0.369 ± 0.03 
Defuran limonin 0.866 ± 0.12 0.793 ± 0.09 1.458 ± 0.54 0.340 ± 0.08 
Limonin glucoside 0.868 ± 0.13 0.756 ± 0.06 1.413 ± 0.08 a 0.447 ± 0.09 
Deacetyl nomilinic 
acid glucoside 
1.151 ± 0.38 0.707 ± 0.13 1.356 ± 0.20 a 0.609 ± 0.12** 
Results are means ± (n=4)  
† specific activity (units/mg protein) 
a
  indicates significant reduction of activity at p<0.05 
** indicates significant induction of activity at p<0.05  
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Fig. 5 GST activity in different organ homogenates against 4-Nitroquinoline 1-oxide, a 
potent xenobiotic tumorigenic to lung, esophagus, forestomach, glandular stomach, skin 
and other organs. Bars indicate mean ± S.D. (n=4). * indicate statistically significant 
inhibition (p<0.05). ** indicate significant induction (p<0.05).  
 
 
 
Quinone reductase activity was measured in lung, intestine, liver and stomach 
homogenates. In liver and lung, limonin-7-methoxime showed significant induction of 
QR 65% and 32%, respectively compared to control. In intestine and stomach 
homogenates, limonin-7-methoxime increased QR activity, but induction was not 
statistically significant. In lung homogenates, defuran limonin showed the highest 
induction (45%) activity. Interestingly, deacetyl nomilinic acid glucoside reduced QR 
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activity in lung. No significant change in activity was observed in stomach homogenates 
(Table 4). 
 
 
Table 4 
Limonoid induction potential of quinone reductase activity†  
Results are means ±SD (n=4)  
† specific activity (units/mg protein) 
a
 indicates significant reduction of activity at p<0.05 
** indicates significant induction of activity at  p<0.05  
 
 
4.5. Discussion 
 A study conducted in the Netherlands, reported that the habitual consumption of 
fruits and vegetables was positively correlated with human rectal GST activity (Wark et 
al., 2004). Recent research on citrus limonoids shows that both limonin and nomilin 
could inhibit certain chemically induced carcinogenesis in different animal models (Lam 
& Hasegawa, 1989; Lam, Zhang, & Hasegawa, 1994; Lam, Zhang, Hasegawa, & Schut, 
Sample 
 
Stomach Intestine Liver  Lung 
Control 8.309 ± 1.73 2.336 ± 0.27 0.520 ± 0.04 0.263 ± 0.05 
Limonin 8.569 ± 1.58 2.474 ± 0.72 0.389 ± 0.10 0.297 ± 0.04 
Limonin-7-
methoxime 
10.455 ± 1.12 4.014 ± 1.15 0.858 ± 0.11** 0.349 ± 0.01** 
Defuran limonin 8.985 ± 0.79 2.005 ± 0.24 0.414 ± 0.02 0.381 ± 0.05** 
Limonin glucoside 8.125 ± 2.38 2.454 ± 0.14 0.479 ± 0.06 0.314 ± 0.05 
Deacetyl nomilinic 
acid glucoside 
9.581 ± 4.07 2.296 ± 0.50 0.238 ± 0.02 a 0.286 ± 0.01 
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1994). In a two stage model for skin carcinogenesis, it was shown that nomilin was more 
effective as an inhibitor during the initiation stage of carcinogenesis, while limonin was 
more active during the promotional phase of carcinogenesis (Lam, Hasegawa, 
Bergstrom, Lam, Kenney, 2000). The main difference between these two limonoids, is 
that limonin has an A and A ring while nomilin has only a seven membered A ring. 
Furthermore, it was suggested that there is a possible induction of GST activity in mice 
by citrus limonoids (Lam & Hasegawa, 1989).  
  The differential induction potential of certain citrus limonoids to induce GST 
activity was later attributed to different structural components of the limonoid nucleus. It 
was suggested that an intact A ring is required for anti-neoplastic effects, such as present 
in nomilin (Miller, Taylor, Berry, Zimmermann, & Hasegawa, 2000). It has also been 
stipulated that modification to the B ring of the limonoid nucleus can also alter the 
induction of GST activity.  
The D-ring of the limonoid nucleus has a furan ring attached to its third position. 
Several studies have been conducted on the importance of the furan ring in the induction 
of GST activity.  Kahweol and cafestrol are two furan containing diterpenes, which are 
reported inducers of GST activity (Lam, Sparnins, & Wattenburg, 1982). All of the 
naturally occurring citrus limonoids contain this furan moiety. All the citrus limonoids 
tested in this study had the furan moiety present except for the modified, defuran 
limonin. Previous studies have shown that the furan moiety plays a role in the induction 
of GST activity (Lam & Hasegawa, 1989).  In the current study, defuran limonin 
exhibited no induction in any of the GST assays. Interestingly, induction of QR activity 
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due to defuran limonin was observed in lung homogenates. It seems that the furan 
moiety may be important for induction of phase II enzymes but not essential to anti-
neoplastic activity. 
  In order to understand the role of A and A’ rings in the limonoids on biological 
activity, the induction potential of citrus limonoids with an open A ring (deacetyl 
nomilinic acid glucoside), and intact A and A rings (limonin, defuran limonin, limonin 
glucoside and limonin-7-methoxime) were analyzed. Previous work has indicated that 
modifications to the A and A rings produce significant differences in the ability to 
induce GST activity (Lam & Hasegawa 1989). Authors demonstrated that citrus 
limonoids with intact A and A rings (limonin, limonol, and deoxylimonin) are not active 
GST inducers, while ichangin, with an open A ring, showed induction of GST. It is clear 
from the previous study that citrus limonoids with only an intact A ring were responsible 
for a majority of the induction activity. Interestingly, on the contrary, our current results 
showed that limonin-7-methoxime, with intact A and A rings and with methoxylation in 
the B ring, had significant GST induction in liver against CDNB and in liver and 
stomach against 4NQO.  In QR assays limonin-7-methoxime showed induction in lung 
and liver homogenates and defuran limonin showed induction in lung only.  Deacetyl 
nomilinic acid glucoside, with an open A ring also showed induction of GST activity in 
lung against CDNB and in stomach against 4NQO. 
 Considering modifications to the B-ring, all of the tested limonoids, except for 
one, contained a ketone at the B ring. In limonin-7methoxime, the ketone was substituted 
by a methoxime functional group, the rest of the limonoid structure was identical to 
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limonin. While limonin did not show any induction activity in any of the enzymatic 
assays performed, limonin-7-methoxime showed induction of phase II enzymes in 
several organ homogenates assayed. Furthermore, limonin-7-methoxime showed 
induction of GST activity in liver homogenate against CDNB. In GST against 4NQO, 
induction was seen in liver and stomach homogenates. Additionally, limonin-7-
methoxime showed QR induction in liver and lung homogenates. Our results strongly 
suggest that modification to the B ring with a methoxy group plays a very important role 
in the induction of phase II detoxifying enzymes, as compared to the inactive limonin. 
 Interestingly, limonin glucoside did not show any induction of Phase II enzyme 
activity in any of the assays performed. It seems that, addition of a glucose moiety 
attached to the D ring of the limonoid nucleus may not play a major role in biological 
activity in relation to Phase II enzymes. 
 The induction of phase II enzymes by citrus limonoids can potentially inhibit 
carcinogenesis by conjugating harmful substances into more water soluble form. The 
increase in polarity of these electrophilic substances facilitates their excretion form the 
body. Furthermore, it has been reported that plant-derived phase II enzyme inducers may 
be potentially important in the incidence of age-related macular degeneration (Zhou, 
Gao, Cai, & Sparrow, 2006). Phase II enzymes are important in the prevention of age-
related degenerative conditions. Induction of phase II enzymes helps in the elimination 
of reactive oxygen species, which accumulate with age. Therefore, citrus limonoids 
could be considered as a potential anti-aging agent by inducing the activity GST and QR.  
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4.6. Conclusion 
  In this study, citrus limonoids with different structural characteristics were 
evaluated to understand their detoxification potential. To the best of our knowledge, this 
is the first study to report on the induction of GST using 4NQO as a substrate. 
Additionally, for the first time, two modified limonoids were also examined for 
induction of the phase II enzymes GST and QR. It is possible that an ample intake of 
citrus fruits may aid in the expulsion of xenobiotics by an increase in activity of phase II 
enzymes.  The ability of these compounds to induce the activity of detoxifying phase II 
enzymes makes them valuable bioactive compounds in the quest of prevent cancer, anti-
aging and oxidative  related diseases, and deserves more in-depth research in order to 
improve human health.  
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CHAPTER V 
 
THE PRESENCE OF PHASE II DETOXIFICATION ENHANCER, D-
GLUCARIC ACID, IN GRAPEFRUIT (Citrus paradisi Macf.)VARIETIES 
 
 
5.1. Synopsis 
 Fruits and vegetables have been reported to contain D-glucaric acid, especially in 
citrus. D-glucaric acid has been reported to possess anticancer properties. In this 
investigation, a method for the quantification of D-glucaric acid in grapefruit by High 
Performance Liquid Chromatography (HPLC) was developed. This HPLC method uses 
an isocratic mobile phase (0.1% phosphoric acid). Nine widely used grapefruit varieties 
were analyzed for the levels of D-glucaric acid. Seasonal levels of GA ranged as follows: 
Thompson (58.36-126.8 mg/100ml), Henderson (29.6-49.7 mg/100ml), Rio Red (40.0-
58.8mg/100ml), Star Ruby (25.5-46.7 mg/100ml), I-48 (26.6-58.3 mg/100ml), Ruby Red 
(49.3-63.0 mg/100ml), Ray’s Ruby (58.2-72.1 mg/100ml), Marsh White (53.7-65.8 
mg/100ml) and Duncan (43.99-64.05 mg/100ml). Seasonal variation of D-glucaric acid 
within the individual varieties was also measured. The overall trend of GA level was 
increased from early to late season in the tested varieties. Our method has a sensitivity of 
detecting D-glucaric acid as low as 0.2 g with accuracy and precision >95%. This 
method was found to be simple, fast, accurate and reproducible. Additionally, the labor 
intensity and cost of sample preparation were greatly reduced as compared to reported 
methods. 
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5.2. Introduction  
 Over the last decade the consumption of citrus products has been positively 
correlated with health benefits (Patil, Brodbelt, Miller, & Turner, 2006; Dwivedi, Heck, 
Downie, Larroya, & Webb, 1990; Walaszek, Szemraj, Hanausek, Adams, & Sherman, 
1996). Studies during this period have found citrus fruits to be rich in bioactive 
compounds, namely, carotenoids, limonoids, flavonoids, pectin, vitamin C, folate, 
furocoumarins, and D-glucaric acid (GA) (Patil, Brodbelt, Miller, & Turner, 2006). 
Previous studies have shown grapefruit and oranges contain high levels of GA (Dwivedi, 
Heck, Downie, Larroya, & Webb, 1990; Walaszek, Szemraj, Hanausek, Adams, & 
Sherman, 1996). Data obtained from two decades of research suggests that consumption 
of dietary GA is helpful in the prevention of carcinogenesis (Walasek, Hanausek-
Walaszek, Minton, & Webb, 1986; Oredipe, Barth, Hanausek-Walaszek, Sautins, 
Walaszek, & Webb; 1987; Walaszek, Flores, & Adams, 1988; Dwivedi, Oredipe, Barth, 
Downie, & Webb, 1989; Walaszek, 1990; Abou-Issa, Koolemans-beynen, & Meredith, 
1992; Oredipe, Barth, Dwivedi, & Webb, 1992; Boone, 1992; Abou-Issa, 1995; Yoshimi, 
Walaszek, Mori, Hanausek, Szenraj, & Slaga, 2000).  
During the last decade, few studies have attempted to measure the content of 
glucarate in fruits and vegetables. In 1990, GA in seven fruits and vegetables was 
measured using an indirect enzymatic inhibition method and HPLC for confirmation 
(Dwivedi, Heck, Downie, Larroya, & Webb, 1990). Sample preparation consisted of 
incubating the sample 0.1M sodium borate to convert the glucarolactone to GA, passing 
the sample through Dowex 1-X8 chromatography. GA was eluted with a 0.05 M sodium 
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borate and 0.02 M sodium sulfate mixture. The presence of GA was confirmed by HPLC 
using a Bio-Rad HPX- H organic acid column. The mobile phase consisted of an 
isocratic elution with 0.01N sulfuric acid containing 10% acetonitrile and detected at 
210 nm. The enzymatic method has the disadvantage that other substances in the sample 
might compete with GA in the inhibition of the enzyme. Furthermore, HPLC was used 
to confirm the presence of GA in the sample. While HPLC procedures are more 
desirable, the use of buffers is tedious and could affect the function of the HPLC 
apparatus over time. In another study in 1996, the contents of 31 fruits and vegetables 
was evaluated by two methods; an enzymatic method and by a pyruvate assay (Walaszek, 
Szemraj, Hanausek, Adams, & Sherman, 1996). The pyruvate assay employs the use of 
bacterial enzymes for the conversion of GA and its lactones to pyruvate. The 
disadvantage of this assay is that it is time consuming and the amount of purified 
enzyme might be limiting. Data from these studies suggest that grapefruit and oranges 
contain higher levels of GA (Dwivedi, Heck, Downie, Larroya, & Webb, 1990; 
Walaszek, Szemraj, Hanausek, Adams, & Sherman, 1996). Other methods of 
determination of D-glucaric acid in urine using chromatographic have been published 
(Poon, Villenueve, Chu, & Kinach, 1993; Gangolli, Longland, & Shilling, 1974; Laakso, 
Tokola, Hirvisalo, 1983; Walters, Lake, Bayley, & Cottrell, 1983). These methods either 
employ the use of complex procedures for the volatilization of GA. In the present study, 
a method was established for the quantification of GA present in different grapefruit 
varieties. Additionally, the seasonal variation of D-glucaric acid content was studied in 
nine varieties of grapefruit.
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5.3. Materials and methods 
5.3.1. Materials 
 Nine varieties of grapefruits (Citrus paradisi Macf.)- such as Rio Red, Star Ruby, 
I-48, Henderson, Ray’s Ruby, Thompson, Marsh White, and Duncan, were obtained 
from Texas A&M University-Kingsville Citrus Center (Weslaco, Texas). Dowex 
50WX2 (mesh size 100), calcium D-saccharate tetrahydrate, and all HPLC grade 
solvents were obtained from Sigma-Aldrich Chemical Co. (St. Louis, MO). Millipore 
water was used for sample preparation and HPLC analysis.   
5.3.2. Resin activation 
 Activation of Dowex 50 (50 g) was carried out by washing of resin four times 
with 150 ml of H2O: HCl (1:1) each wash was carried out for 15 min. The resin was 
filtered and rinsed with distilled water until neutral pH. 
5.3.3. Sample collection and preparation 
Ten fruits from each variety were harvested from the same tree, and the tree was 
labelled for future harvesting. The fruits were collected on: November 5 (early season), 
February 5 (mid- season), and May 5 (late season). Each variety of grapefruit was peeled 
and made into homogenous juice, separately. Samples were composed of two fruits, 
which yields 700-1000ml of juice. Aliquots (1.5ml) were centrifuged (Eppendorf 5417C, 
Westbury, NY, USA) at 10,000 rpm for 25 min., in order to remove pulp material. The 
supernatant was then filtered through a 0.45 m syringe filter (Whatman, Florham Park, 
NJ, USA)  and stored at -80°C until subjected to HPLC analysis of GA. 
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5.3.4. Preparation of free GA  
 At present, GA standard is not commercially available in market. Hence calcium 
D-saccharate tetrahydrate was deionized for the preparation of free GA as follows. 
Calcium D-saccharate tetrahydrate (300 mg)  was suspended in 15 ml of water and was 
treated with 3g of Dowex 50 [H+]. The mixture was stirred with a magnetic stirrer for 20 
min and the supernatant was decanted into a 100 ml volumetric flask. Water wash was 
continued until neutral pH was achieved. Supernatants and washings were combined and 
the volume was made up to 100 ml. 
5.3.5. HPLC analysis 
Chromatographic separation of GA was achieved by means of a Perkin Elmer 
(Perkin Elmer, Boston USA) Series 200 pump coupled with a Perkin Elmer Series 200 
autosampler and a Perkin Elmer Series 200 UV/VIS detector using a Hydro-RP column 
(250 mm x 4.6 I.D.) 4µm particle size (Phenomenex, Torrance, CA, USA).  An isocratic 
mobile phase of 0.1% phosphoric acid (v/v) was used at a flow rate of 1 ml/min.  GA 
was detected at 210nm. For quantification of GA, the Turbochrome Navigator software 
version 6.2.1. was used. 
5.3.6. Calibration and linearity 
 The linearity of the method was analyzed by evaluating a series 1.2, 2.4, 4.9, 9.9, 
19.8 g of standard GA. Fifteen microliters of the five standard solutions of standard GA 
were injected into HPLC. A calibration curve was obtained by plotting the concentration 
of GA versus the average peak area from triplicate runs. A range of calibration 
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concentrations was chosen to reflect the normal D-glucaric acid concentration present in 
grapefruit samples.  
5.3.7. Limit of quantification 
The limit of quantification was defined as the lowest GA concentration which 
can be determined with an accuracy and precision of > 95%.  The lower limit of 
quantification was determined to be to a level of 0.03 g. 
5.3.8. Quantification of GA in samples 
 Fifteen microliters of each sample were injected into HPLC for the analysis of 
GA in grapefruit samples. The concentration of GA present in each sample was 
calculated by application of the linear calibration function, incorporating a dilution 
factor.  GA content of grapefruit was presented as mg /100 ml of grapefruit juice.  
5.4. Results  
We employed the use of a Synergy Hydro-RP column (Phenomenex, Torrance, 
CA, USA) of 4 micron particle size (250mm x 4.6 I.D.) for the separation of GA from 
grapefruit juice. D-Glucaric acid was separated with an isocratic mobile phase of 0.1% 
phosphoric acid (v/v), at a flow rate of 1 ml/min. The D-glucaric acid peak was eluted at 
2.84 min retention time (Fig. 6). Figure 7 depicts a typical grapefruit sample and a 
grapefruit sample with a GA spike.  
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Fig.6. Chromatogram for standard D-glucaric acid  
 
  
68 
 
 
Fig.7. Chromatograms of grapefruit samples. (A) typical grapefruit sample, (B) 
grapefruit sample with a GA spike 
 
 
 
Fig.8. depicts the D- glucaric acid concentration of fruit harvested in November. 
Thompson varieties had the highest content of D-glucaric acid, 126.8 mg/100ml. The  
Marsh (65.8 mg/100ml), Ruby Red (63.0 mg/100ml), Ray’s Ruby (58.2mg/100ml), 
Duncan (50.17 mg/100ml),  Henderson (44.3mg/100ml) and Rio Red (41.2mg/100ml) 
varieties all displayed similar midrange levels of GA, while the Star Ruby (25.5 
45
95
145
195
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0
45
95
145
195
245
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0
B 
A 
  
69 
mg/100ml) and the I-48 (26.7 mg/100ml) varieties had  significantly lower levels of GA 
than Thompson variety.  
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Fig.8. Level of D-glucaric acid (GA) in grapefruit varieties harvested in November 
 
 
 
 
Concentrations of D-glucaric acid in grapefruit harvested in February followed a 
similar trend from that of the early season harvest. Thompson, a pink grapefruit, again 
had the highest concentration of D-glucaric acid, 85.9 mg/100ml. The midrange varieties 
were Duncan (64.05 mg/100ml), Ray’s Ruby (63.4 mg/ml), Marsh (53.7 mg/100ml), 
Ruby Red (49.3 mg/100ml), Star Ruby (46.7 mg/100ml), I-48 (41.9), and Rio Red (40.1 
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mg/100ml). From the mid-season harvest, the Henderson yielded the lowest levels of D-
glucaric acid, 29.6 mg/100ml (Fig.9).  
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Fig.9. Level of D-glucaric acid (GA) in grapefruit varieties harvested in February  
 
 
 
 
The results from the May harvest showed similar results. The Ray’s Ruby variety 
displayed the highest content of D-glucaric acid, 72.2 mg/ml. The D-glucaric acid level 
of the Ray’s Ruby variety was followed by the Rio Red (58.8 mg/100ml), Thompson 
(58.4 mg/100ml), I-48 (58.3 mg/100ml), Ruby Red (55.0 mg/100ml), and Marsh (54.0 
mg/100ml) variety grapefruits. The Henderson (49.7 mg/100mg), Duncan (43.9 
mg/100ml), and Star Ruby (43.5 mg/100ml) varieties were observed to contain the least 
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D-glucaric acid content in the fruit harvested in the month of May (Fig.10). The trend in 
seasonal changes of GA for the nine grapefruit varieties is illustrated in figure 11. 
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Fig.10. Level of D-glucaric acid (GA) in grapefruit varieties harvested in May  
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Fig.11. Seasonal variation of D-glucaric acid content in grapefruit 
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We have presented data obtained from a simple isocratic HPLC method for the 
determination of D-glucaric acid. This analytical procedure displayed optimal and 
reproducible results for the quantification of D-glucaric acid. The linear relationship 
between the D-glucaric acid concentration and the peak area using our reported method 
was determined using six concentrations, 1.2, 2.4, 4.9, 9.9, and 19.8g injected in 
triplicate. The regression coefficient for the D-glucaric acid calibration curve was 0.996 
(fig12). The lower limit for detection of D-glucaric acid was found to be 0.07 g. 
 
 
 
 
GA Standard Curve
y = 622.01x + 197.65
R2 = 0.9997
0
2000
4000
6000
8000
10000
12000
14000
0 5 10 15 20 25
Micrograms of GA
A
re
a
 
 
Fig.12. Calibration curve for D-glucaric acid (GA). 
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5.5. Discussion 
 Citrus fruit contain many bioactive compounds, including D-glucaric acid. 
Several studies have reported measurements of D-glucaric acid, but current methods are 
expensive, laborious, and in some cases only useful for qualitative analysis (Dwivedi, 
Heck, Downie, Larroya, & Webb, 1990; Walaszek, Szemraj, Hanausek, Adams, & 
Sherman, 1996; Poon, Villenueve, Chu, & Kinach, 1993; Gangolli, Longland, & 
Shilling, 1974; Laakso, Tokola, Hirvisalo, 1983; Walters, Lake, Bayley, & Cottrell, 
1983). The work performed to date on the analysis of D-glucaric acid is summarized in 
Table 5. The purpose of this study is to develop a method that will be useful for the 
quantitative analysis of D-glucaric acid in fruit, namely grapefruit, while avoiding the 
previously stated disadvantages. Our reported method is a cost effective, fast and simple 
isocratic HPLC method for the quantification of D-glucaric acid in grapefruit. 
Results from previous studies indicate a high content of D-glucarate in various 
fruits and vegetables (Dwivedi, Heck, Downie, Larroya, & Webb, 1990; Walaszek, 
Szemraj, Hanausek, Adams, & Sherman, 1996). Furthermore, these studies indicated 
that citrus fruits had the highest levels of D-glucaric acid. Based on the potential role of 
D-glucaric acid in human health, we developed a method for the quantification of D-
glucaric acid in grapefruit varieties. 
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Table 5 
Quantification of D-glucaric acid used by previous studies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Author Year Method HPLC Conditions Sample treat. Origin 
Walters et al. 
 
 
1983 
 
 
HPLC 
 
 
Partisil-10 SAX 
(250x4.6) col., 0.06M 
KH2PO4 adjusted to 
6pH w/NaOH 
@2ml/min, 200nm 
 
Centrifugation 
 
 
Urine 
 
 
Laakso et al. 
 
 
1983 
 
 
HPLC 
 
 
 
Spherisorb-NH2, 
5um(228x5), 0.01M 
H2PO4-Acetonitrile 
(75:25) @2ml/min 
220 nm 
 
Made solution 
basic 
 
Urine 
 
 
Dwivedi et al. 
 
 
1990 
 
 
Enzyme/  
HPLC 
 
 
Bio-Rad HPX-87H 
organic acid col. 
Isocratic 0.01N 
Sulfuric 
w/10%acetonitrile  
210nm 
 
Cent., Boiling,  
Buffer 
 
Fruits 
&Veg. 
 
 
Poon et al. 
 
 
1993 
 
 
HPLC 
 
 
 
Aminex HPX-87H 
(75x300), 0.004N 
 sulfiric acid 
@0.5ml/min 210 nm 
 
Affi-gel 601 
 
 
Urine 
 
 
Walaszek et al. 
 
1996 
 
Enzyme/ 
 pyruvate 
 
 
 
 Fruit & 
Veg. 
 
Lampe et al. 
 
2002 
 
Enzyme 
 
 
 
 Food 
 
Jung et al. 
 
1981 
 
Enzyme 
 
 
 
 Urine 
 
 
Mocarelli et al. 
 
1988 
 
Enzyme 
 
 
 
 Urine 
 
Steinberg et al. 
 
 
1986 
 
 
Enzyme / 
Glyoxylic 
 
 
 
 
 Urine 
 
 
Marsh 
 
 
1985 
 
 
Enzyme/ 
Pyruvate 
 
  Urine 
 
 
Kringstad et al. 
 
1975 
 
TLC 
 
  Plants 
 
Walaszek et al. 
 
1997 
 
HPLC/ 
Enzyme 
Spherisorb-NH2, 
0.01Mphosphoric 
acid -Acetonitrile 
@1.5ml/min 200nm 
 Urine/ 
organ 
extract. 
 
Gangolli et al. 
 
 
1974 
 
 
GC 
 
  
Volatilization  
 
 
Urine 
 
Colombi et al. 1983 
 
Enzyme 
 
  Urine 
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Initially, difficulties faced to obtain standards. For our study, calcium D-
saccharate tetrahydrate was subject to ion exchange chromatography to obtain free GA. 
Once free GA was obtained, the development and validation of the method was carried 
out. The analytical method consisted of a direct injection of sample to HPLC. The GA 
peak was eluted with an isocratic (0.1% phosphoric acid) mobile phase. The sample 
preparation was minimal, consisting mainly of homogenization and filtration. The 
analysis of grapefruit samples was completed in 15 min. Furthermore, the sensitivity of 
our method was able to detect level of GA as low as 0.03g. 
 Differences were observed in the level of D-glucaric acid among the nine 
grapefruit varieties tested. Furthermore, seasonal changes of D-glucaric acid levels were 
also observed within individual varieties to varying degrees.  In early season, grapefruit 
D-glucaric acid content varies from 25-126 mg/100ml. Interestingly, the range of D-
glucaric acid levels in late season fruits is much narrower (43-72 mg/100ml). In some 
instances the D-glucaric aicd level increased in an individual grapefruit variety, while 
decreases in levels were observed in others. Levels of D-glucaric acid increased in the I-
48, Star Ruby, Ray’s Ruby, and Rio Red varieties from early to late season. Inversely, 
Duncan, Ruby Red, and Thompson varieties showed a decreasing trend in levels of D-
glucaric acid as the season progressed. The Marsh variety showed no fluctuation in 
levels of D-glucaric acid, maintaining a mid range level, compared to other varieties 
through out the season (Table 6).   
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Table 6 
Changes in D-glucaric acid levels from early to late season fruits. 
 
 
 
 
 
 
 
 
 
 
A general feature of the development of citrus fruits is the accumulation of 
organic acids at early fruit development (Erickson, 1968). This accumulation of GA 
reaches a peak and decreases at maturity. It has been postulated that the final organic 
acid content in mature fruit is determined by an equilibrium between synthesis, storage 
and mobilization (Laval-Martin, Farineau, & Diamond, 1977; Müller, Irkens-Kiesecker, 
Bubinstein, & Taiz, 1996; Ruffner, Possner, Brem, & Rast, 1984). In other instances, 
this decrease in organic acid content in Hamlin oranges, mainly citric and malic acid, 
has been attributed to their dilution due to fruit expansion (Ting & Vines, 1966). This 
decrease in levels of organic acids has been mainly observed in major organic acids, 
while less prominent acids, tartartic, succinic, and ascorbic acid, have been observed to 
remain relatively constant during fruit development (Albertini, Carcouet, Pailly, 
Gambotti, Luro, & Berti, 2006). Furthermore, it has also been noted that the organic acid 
content varies greatly within individual fruit species (Moing, Svanella, Gaudillere, 
Variety Early Season  
(November) 
mg/100ml 
Late Season 
(May) 
mg/100ml 
 Ratio 
Early/Late 
Marsh 53.69 ± 8.6 54.03 ± 8.6  1.00 
Star Ruby  25.59 ± 1.5 43.53 ± 10.6  1.70 
Duncan 64.05 ± 16.0 43.99 ± 16.8  0.68 
I-48 26.68 ± 6.6 58.36 ± 14.2  2.18 
Ray’s Ruby 58.19 ± 11.7 72.16 ± 7.7  1.24 
Ruby Red 63.03 ± 13.2 55.01 ± 7.9  0.87 
Henderson 44.29 ± 11.8 49.71 ± 12.4  1.12 
Rio Red 41.20 ± 9.8 58.80 ± 12.4  1.42 
Thompson 126.82 ± 21.1 58.43 ± 16.1  0.47 
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Gaudillere, & Monet, 1999). Recent studies have attributed to the changes in organic 
acid contents in fruit to the catabolic actions of various enzymes, mainly aconitase and 
phosphoenopyruvate carboxykinase (Sadka, Dahn, Cohen, & Marsh, 2000; Famiani et 
al., 2005).  It is interesting to note that there have been very few studies measuring the 
D-glucaric acid levels in fruit. To the best of our knowledge, seasonal variations of D-
glucaric acid have not been previously reported.  
  Several studies have developed HPLC methods for the quantification of D-
glucaric acid, mainly from urine (Poon, Villenueve, Chu, & Kinach, 1993; Laakso, 
Tokola, & Hirvisalo, 1983; Walters, Lake, Bayley, & Cottrell, 1983). These methods 
involve tedious sample preparation and expensvive.  Furthermore, the date obtained 
from some of these studies was mainly qualitative. In this investigation, we report a 
simple isocratic HPLC method for the quantification of D-glucaric acid in grapefruit 
samples which is quick, accurate, and reproducible.   
5.6. Conclusion  
 A new method for the quantification of D-glucaric acid is developed which is 
accurate and reproducible compared to previously reported methods. D-glucaric acid has 
been extensively studied in several animal models for the prevention of chemical 
carcinogenesis. Furthermore, it has also been reported that D-glucaric acid is present in 
various fruits and vegetables, including citrus. We measured the D-glucaric acid content 
of nine grapefruit varieties and found that level of D-Glucaric acid ranged from 25-126 
mg/100ml of grapefruit homogenate. Data from this investigation could be helpful in the 
fight against cancer by introducing a new, quick and reliable analytical method for food 
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analysis. By using this method and results from animal studies, nutritional scientists 
could recommend an appropriate intake of fruits and vegetable high in D-glucaric acid 
content for chemoprevention.     
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CHAPTER VI  
CONCLUSION 
 
 Phase II enzyme activity is known to be one of the major mechanisms for 
chemoprevention. Several bioactive compounds have been reported to induce the 
activity of these enzymes. In this project, the inductive properties of citrus limonoids on 
GST and QR were investigated in vivo. It was found that variations in the limonoid 
structures influence the degree in induction of these enzymes. This was most notable in 
the methoxylation of limonin.  
 Furthermore, a method for the quantification of D-glucaric acid, a reported phase 
II detoxification enhancer, was developed. GA has previously been reported to be 
present in fruits and vegetables. Our method consisted of sample filtration and analysis 
by high performance liquid chromatography using an isocratic mobile phase. Compared 
to previous methods, this method is simple, quick and reproducible. An accurate 
determination of GA is essential for dietary recommendations of fruits and vegetables 
for possible chemoprevention. 
 The consumption of fruits and vegetables has been repeatedly correlated with 
positive health effects. A time has progressed and technology improved, these health 
promoting properties have been linked to specific bioactive compound present in the 
food we consume.  Further studies are needed to elucidate the chemopreventive 
mechanisms of bioactive compounds found in citrus. Additionally, studies are also 
needed on the synergistic effects various bioactive compounds.  
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APPENDIX 
 
Abbreviations Definition 
 
(1,4)-GL (1,4)-Glucarolactone 
 
4NQO 4-nitroquinoline 1-oxide 
 
(6,3)-GL (6,3)-Glucarolactone 
 
BSA Bovine serum albumin  
 
CDNB 1-chloro-2,4-dinitrobenzene 
 
DCPIP 2,6-dichlorophenol-indophenol 
 
GA D-Glucaric acid 
 
GST Glutathione S-transferase 
 
GSH Glutathione (reduced) 
 
HCL Hydrochloric acid  
 
HPLC High performance liquid chromatography 
 
PBS Phosphate buffer solution 
 
QR NAD(P)H: quinone reductase 
 
UDPGT UDP-glucuronosyltransferase 
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